<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2020-10-07" version="268">
<accession>P10636</accession>
<accession>P18518</accession>
<accession>Q14799</accession>
<accession>Q15549</accession>
<accession>Q15550</accession>
<accession>Q15551</accession>
<accession>Q1RMF6</accession>
<accession>Q53YB1</accession>
<accession>Q5CZI7</accession>
<accession>Q5XWF0</accession>
<accession>Q6QT54</accession>
<accession>Q9UDJ3</accession>
<accession>Q9UMH0</accession>
<accession>Q9UQ96</accession>
<name>TAU_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="92">Microtubule-associated protein tau</fullName>
</recommendedName>
<alternativeName>
<fullName>Neurofibrillary tangle protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Paired helical filament-tau</fullName>
<shortName>PHF-tau</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="94">MAPT</name>
<name type="synonym">MAPTL</name>
<name type="synonym">MTBT1</name>
<name type="synonym">TAU</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="4051" last="4055">
<title>Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.</title>
<authorList>
<person name="Goedert M."/>
<person name="Wischik C."/>
<person name="Crowther R."/>
<person name="Walker J."/>
<person name="Klug A."/>
</authorList>
<dbReference type="PubMed" id="3131773"/>
<dbReference type="DOI" id="10.1073/pnas.85.11.4051"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FETAL-TAU)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="EMBO J." volume="8" first="393" last="399">
<title>Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.</title>
<authorList>
<person name="Goedert M."/>
<person name="Spillantini M.G."/>
<person name="Potier M.-C."/>
<person name="Ulrich J."/>
<person name="Crowther R.A."/>
</authorList>
<dbReference type="PubMed" id="2498079"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1989.tb03390.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TAU-D)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="Neuron" volume="2" first="1615" last="1624">
<title>The microtubule binding domain of tau protein.</title>
<authorList>
<person name="Lee G."/>
<person name="Neve R.L."/>
<person name="Kosik K.S."/>
</authorList>
<dbReference type="PubMed" id="2516729"/>
<dbReference type="DOI" id="10.1016/0896-6273(89)90050-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-A AND FETAL-TAU)</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1989" name="Neuron" volume="3" first="519" last="526">
<title>Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.</title>
<authorList>
<person name="Goedert M."/>
<person name="Spillantini M.G."/>
<person name="Jakes R."/>
<person name="Rutherford D."/>
<person name="Crowther R.A."/>
</authorList>
<dbReference type="PubMed" id="2484340"/>
<dbReference type="DOI" id="10.1016/0896-6273(89)90210-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-B; TAU-C; TAU-E AND TAU-F)</scope>
<scope>ASSOCIATION WITH ALZHEIMER DISEASE</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1992" name="Biochemistry" volume="31" first="10626" last="10633">
<title>Structure and novel exons of the human tau gene.</title>
<authorList>
<person name="Andreadis A."/>
<person name="Brown W.M."/>
<person name="Kosik K.S."/>
</authorList>
<dbReference type="PubMed" id="1420178"/>
<dbReference type="DOI" id="10.1021/bi00158a027"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS PNS-TAU; FETAL-TAU AND TAU-F)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>VARIANT HIS-441</scope>
</reference>
<reference key="6">
<citation type="submission" date="2004-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of tau-related genes.</title>
<authorList>
<person name="Chun J."/>
<person name="Kwon T."/>
<person name="Lee E.-J."/>
<person name="Hyun S.-H."/>
<person name="Kang S.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TAU-E)</scope>
</reference>
<reference key="7">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM FETAL-TAU)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS FETAL-TAU AND TAU-D)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="17047" last="17054">
<title>Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain.</title>
<authorList>
<person name="Hasegawa M."/>
<person name="Morishima-Kawashima M."/>
<person name="Takio K."/>
<person name="Suzuki M."/>
<person name="Titani K."/>
<person name="Ihara Y."/>
</authorList>
<dbReference type="PubMed" id="1512244"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-73; 103-381; 468-497; 508-571; 577-583; 592-607; 616-634; 639-657; 661-664; 671-700 AND 703-758</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>DEAMIDATION AT ASN-484 AND ASN-596</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 25-44; 529-538; 560-571 AND 671-686</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="12">
<citation type="submission" date="2004-01" db="EMBL/GenBank/DDBJ databases">
<title>Molecular interactions of recombinant neural protein tau with recombinant and native PrP proteins in vitro.</title>
<authorList>
<person name="Han J."/>
<person name="Zhang J."/>
<person name="Dong X.-P."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 466-740 (ISOFORMS TAU-A/TAU-B/TAU-C/FETAL-TAU)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="10825" last="10838">
<title>Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation.</title>
<authorList>
<person name="Cripps D."/>
<person name="Thomas S.N."/>
<person name="Jeng Y."/>
<person name="Yang F."/>
<person name="Davies P."/>
<person name="Yang A.J."/>
</authorList>
<dbReference type="PubMed" id="16443603"/>
<dbReference type="DOI" id="10.1074/jbc.m512786200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 543-551; 560-574; 576-584 AND 623-634</scope>
<scope>PHOSPHORYLATION AT SER-531; THR-534; THR-548; SER-552; SER-554; SER-579; SER-713 AND SER-739</scope>
<scope>UBIQUITINATION AT LYS-571; LYS-628 AND LYS-670</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="7679" last="7688">
<title>Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.</title>
<authorList>
<person name="Drewes G."/>
<person name="Trinczek B."/>
<person name="Illenberger S."/>
<person name="Biernat J."/>
<person name="Schmitt-Ulms G."/>
<person name="Meyer H.E."/>
<person name="Mandelkow E.-M."/>
<person name="Mandelkow E."/>
</authorList>
<dbReference type="PubMed" id="7706316"/>
<dbReference type="DOI" id="10.1074/jbc.270.13.7679"/>
</citation>
<scope>PROTEIN SEQUENCE OF 577-584; 608-611; 616-628; 639-648 AND 671-686</scope>
<scope>PHOSPHORYLATION AT SER-579; SER-610; SER-622; SER-641 AND SER-673</scope>
<scope>MUTAGENESIS</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1989" name="Biochem. Biophys. Res. Commun." volume="159" first="1221" last="1226">
<title>A distinct form of tau is selectively incorporated into Alzheimer's paired helical filaments.</title>
<authorList>
<person name="Mori H."/>
<person name="Hamada Y."/>
<person name="Kawaguchi M."/>
<person name="Honda T."/>
<person name="Kondo J."/>
<person name="Ihara Y."/>
</authorList>
<dbReference type="PubMed" id="2495000"/>
<dbReference type="DOI" id="10.1016/0006-291x(89)92240-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 592-622 (ISOFORMS PNS-TAU/TAU-D/TAU-E/TAU-F)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1991" name="Science" volume="251" first="675" last="678">
<title>A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.</title>
<authorList>
<person name="Lee V.M."/>
<person name="Balin B.J."/>
<person name="Otvos L. Jr."/>
<person name="Trojanowski J.Q."/>
</authorList>
<dbReference type="PubMed" id="1899488"/>
<dbReference type="DOI" id="10.1126/science.1899488"/>
</citation>
<scope>PROTEIN SEQUENCE OF 251-264 AND 379-392</scope>
<scope>PHOSPHORYLATION AT SER-396</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1991" name="EMBO J." volume="10" first="2725" last="2729">
<title>Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease.</title>
<authorList>
<person name="Jakes R."/>
<person name="Novak M."/>
<person name="Davison M."/>
<person name="Wischik C.M."/>
</authorList>
<dbReference type="PubMed" id="1915258"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1991.tb07820.x"/>
</citation>
<scope>PROTEIN SEQUENCE OF 616-712</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="277" last="295">
<title>The role of tau (MAPT) in frontotemporal dementia and related tauopathies.</title>
<authorList>
<person name="Rademakers R."/>
<person name="Cruts M."/>
<person name="van Broeckhoven C."/>
</authorList>
<dbReference type="PubMed" id="15365985"/>
<dbReference type="DOI" id="10.1002/humu.20086"/>
</citation>
<scope>IDENTIFICATION (ISOFORM TAU-G)</scope>
<scope>VARIANT HIS-441</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1991" name="Trends Neurosci." volume="14" first="193" last="199">
<title>Molecular characterization of microtubule-associated proteins tau and MAP2.</title>
<authorList>
<person name="Goedert M."/>
<person name="Crowther R.A."/>
<person name="Garner C.C."/>
</authorList>
<dbReference type="PubMed" id="1713721"/>
<dbReference type="DOI" id="10.1016/0166-2236(91)90105-4"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="1777" last="1785">
<title>The regulatory Ser262 of microtubule-associated protein tau is phosphorylated by phosphorylase kinase.</title>
<authorList>
<person name="Paudel H.K."/>
</authorList>
<dbReference type="PubMed" id="8999860"/>
</citation>
<scope>PHOSPHORYLATION AT SER-554; SER-579; SER-602; SER-622 AND SER-669</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1997" name="J. Neurochem." volume="69" first="1709" last="1719">
<title>Characterization of in vitro glycation sites of tau.</title>
<authorList>
<person name="Nacharaju P."/>
<person name="Ko L."/>
<person name="Yen S.H."/>
</authorList>
<dbReference type="PubMed" id="9326300"/>
<dbReference type="DOI" id="10.1046/j.1471-4159.1997.69041709.x"/>
</citation>
<scope>GLYCATION AT LYS-87; LYS-383; LYS-467; LYS-480; LYS-491; LYS-542; LYS-551; LYS-576; LYS-597; LYS-598; LYS-664; LYS-670 AND LYS-686</scope>
<scope>LACK OF GLYCATION AT LYS-24; LYS-44; LYS-67; LYS-381; LYS-391; LYS-392; LYS-394; LYS-465; LYS-497; LYS-507; LYS-541; LYS-557; LYS-571; LYS-574; LYS-584; LYS-591; LYS-607; LYS-611; LYS-615; LYS-628; LYS-634; LYS-638; LYS-648; LYS-657; LYS-660; LYS-687; LYS-692; LYS-700; LYS-702; LYS-712 AND LYS-755</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1998" name="Arch. Biochem. Biophys." volume="357" first="299" last="309">
<title>Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.</title>
<authorList>
<person name="Sengupta A."/>
<person name="Kabat J."/>
<person name="Novak M."/>
<person name="Wu Q."/>
<person name="Grundke-Iqbal I."/>
<person name="Iqbal K."/>
</authorList>
<dbReference type="PubMed" id="9735171"/>
<dbReference type="DOI" id="10.1006/abbi.1998.0813"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1998" name="Mol. Biol. Cell" volume="9" first="1495" last="1512">
<title>The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease.</title>
<authorList>
<person name="Illenberger S."/>
<person name="Zheng-Fischhofer Q."/>
<person name="Preuss U."/>
<person name="Stamer K."/>
<person name="Baumann K."/>
<person name="Trinczek B."/>
<person name="Biernat J."/>
<person name="Godemann R."/>
<person name="Mandelkow E.-M."/>
<person name="Mandelkow E."/>
</authorList>
<dbReference type="PubMed" id="9614189"/>
<dbReference type="DOI" id="10.1091/mbc.9.6.1495"/>
</citation>
<scope>PHOSPHORYLATION AT THR-470; SER-516; SER-519; THR-529; SER-531; SER-552; SER-579; SER-713; SER-721 AND SER-739</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="15733" last="15740">
<title>Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments.</title>
<authorList>
<person name="Maas T."/>
<person name="Eidenmueller J."/>
<person name="Brandt R."/>
</authorList>
<dbReference type="PubMed" id="10747907"/>
<dbReference type="DOI" id="10.1074/jbc.m000389200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15938" last="15945">
<title>Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.</title>
<authorList>
<person name="Li G."/>
<person name="Yin H."/>
<person name="Kuret J."/>
</authorList>
<dbReference type="PubMed" id="14761950"/>
<dbReference type="DOI" id="10.1074/jbc.m314116200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-519; THR-522; SER-713 AND SER-721 BY CSNK1D/CK1</scope>
<scope>INTERACTION WITH CSNK1D</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Neurochem." volume="88" first="349" last="358">
<title>Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules.</title>
<authorList>
<person name="Cho J.H."/>
<person name="Johnson G.V."/>
</authorList>
<dbReference type="PubMed" id="14690523"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2004.02155.x"/>
</citation>
<scope>PHOSPHORYLATION AT THR-548 BY GSK3B</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="J. Neurosci." volume="24" first="2304" last="2312">
<title>Phosphorylation of tau by fyn: implications for Alzheimer's disease.</title>
<authorList>
<person name="Lee G."/>
<person name="Thangavel R."/>
<person name="Sharma V.M."/>
<person name="Litersky J.M."/>
<person name="Bhaskar K."/>
<person name="Fang S.M."/>
<person name="Do L.H."/>
<person name="Andreadis A."/>
<person name="Van Hoesen G."/>
<person name="Ksiezak-Reding H."/>
</authorList>
<dbReference type="PubMed" id="14999081"/>
<dbReference type="DOI" id="10.1523/jneurosci.4162-03.2004"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-18 BY FYN</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="J. Neurochem." volume="94" first="192" last="203">
<title>Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation.</title>
<authorList>
<person name="Babu J.R."/>
<person name="Geetha T."/>
<person name="Wooten M.W."/>
</authorList>
<dbReference type="PubMed" id="15953362"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2005.03181.x"/>
</citation>
<scope>INTERACTION WITH SQSTM1</scope>
<scope>UBIQUITINATION</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="1790" last="1796">
<title>Dephosphorylation of tau by protein phosphatase 5: impairment in Alzheimer's disease.</title>
<authorList>
<person name="Liu F."/>
<person name="Iqbal K."/>
<person name="Grundke-Iqbal I."/>
<person name="Rossie S."/>
<person name="Gong C.X."/>
</authorList>
<dbReference type="PubMed" id="15546861"/>
<dbReference type="DOI" id="10.1074/jbc.m410775200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-498; SER-516; SER-519; THR-522; THR-529; SER-531; THR-548; SER-552; SER-579; SER-713; SER-721 AND SER-726</scope>
<scope>DEPHOSPHORYLATION AT THR-498; SER-516; SER-519; THR-522; THR-529; SER-531; THR-548; SER-552; SER-579; SER-713; SER-721 AND SER-726 BY PPP5C</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="J. Neurochem." volume="98" first="1573" last="1584">
<title>Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation.</title>
<authorList>
<person name="Sato S."/>
<person name="Cerny R.L."/>
<person name="Buescher J.L."/>
<person name="Ikezu T."/>
</authorList>
<dbReference type="PubMed" id="16923168"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2006.04059.x"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-514; SER-515; SER-516; SER-519; SER-733; SER-739 AND THR-744</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="8357" last="8370">
<title>Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite formation through microtubule depolymerization by SGK1 and by SGK1 phosphorylation of tau.</title>
<authorList>
<person name="Yang Y.C."/>
<person name="Lin C.H."/>
<person name="Lee E.H."/>
</authorList>
<dbReference type="PubMed" id="16982696"/>
<dbReference type="DOI" id="10.1128/mcb.01017-06"/>
</citation>
<scope>PHOSPHORYLATION AT SER-214 BY SGK1</scope>
<scope>INTERACTION WITH SGK1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="23645" last="23654">
<title>Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.</title>
<authorList>
<person name="Hanger D.P."/>
<person name="Byers H.L."/>
<person name="Wray S."/>
<person name="Leung K.-Y."/>
<person name="Saxton M.J."/>
<person name="Seereeram A."/>
<person name="Reynolds C.H."/>
<person name="Ward M.A."/>
<person name="Anderton B.H."/>
</authorList>
<dbReference type="PubMed" id="17562708"/>
<dbReference type="DOI" id="10.1074/jbc.m703269200"/>
</citation>
<scope>PHOSPHORYLATION BY CSNK1D/CK1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Biochem. Pharmacol." volume="76" first="1389" last="1394">
<title>Role for DYRK family kinases on regulation of apoptosis.</title>
<authorList>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="18599021"/>
<dbReference type="DOI" id="10.1016/j.bcp.2008.05.021"/>
</citation>
<scope>PHOSPHORYLATION AT THR-529 BY DYRK2</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-519</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Brain" volume="132" first="1820" last="1832">
<title>Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.</title>
<authorList>
<person name="Liu F."/>
<person name="Shi J."/>
<person name="Tanimukai H."/>
<person name="Gu J."/>
<person name="Gu J."/>
<person name="Grundke-Iqbal I."/>
<person name="Iqbal K."/>
<person name="Gong C.X."/>
</authorList>
<dbReference type="PubMed" id="19451179"/>
<dbReference type="DOI" id="10.1093/brain/awp099"/>
</citation>
<scope>GLYCOSYLATION</scope>
<scope>PHOSPHORYLATION AT SER-516; SER-519; THR-522; THR-529; SER-531; THR-534; SER-579; SER-713; SER-721 AND SER-739</scope>
<scope>ASSOCIATION WITH ALZHEIMER DISEASE</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="22657" last="22663">
<title>Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease.</title>
<authorList>
<person name="Puri R."/>
<person name="Suzuki T."/>
<person name="Yamakawa K."/>
<person name="Ganesh S."/>
</authorList>
<dbReference type="PubMed" id="19542233"/>
<dbReference type="DOI" id="10.1074/jbc.m109.009688"/>
</citation>
<scope>INTERACTION WITH EPM2A</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-713; SER-717; SER-721 AND SER-726</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Mol. Biosyst." volume="7" first="1420" last="1429">
<title>Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.</title>
<authorList>
<person name="Smet-Nocca C."/>
<person name="Broncel M."/>
<person name="Wieruszeski J.M."/>
<person name="Tokarski C."/>
<person name="Hanoulle X."/>
<person name="Leroy A."/>
<person name="Landrieu I."/>
<person name="Rolando C."/>
<person name="Lippens G."/>
<person name="Hackenberger C.P."/>
</authorList>
<dbReference type="PubMed" id="21327254"/>
<dbReference type="DOI" id="10.1039/c0mb00337a"/>
</citation>
<scope>GLYCOSYLATION AT SER-525; SER-555 AND SER-717</scope>
<scope>PHOSPHORYLATION AT SER-519; SER-713 SER-717 AND SER-721</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="J. Neurochem." volume="120" first="165" last="176">
<title>Phosphorylation of microtubule-associated protein tau by AMPK-related kinases.</title>
<authorList>
<person name="Yoshida H."/>
<person name="Goedert M."/>
</authorList>
<dbReference type="PubMed" id="21985311"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2011.07523.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-529 AND SER-579</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-519; THR-548; SER-552; SER-713 AND SER-721</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="NeuroMolecular Med." volume="15" first="458" last="469">
<title>Role of individual MARK isoforms in phosphorylation of tau at Ser262 in Alzheimer's disease.</title>
<authorList>
<person name="Gu G.J."/>
<person name="Lund H."/>
<person name="Wu D."/>
<person name="Blokzijl A."/>
<person name="Classon C."/>
<person name="von Euler G."/>
<person name="Landegren U."/>
<person name="Sunnemark D."/>
<person name="Kamali-Moghaddam M."/>
</authorList>
<dbReference type="PubMed" id="23666762"/>
<dbReference type="DOI" id="10.1007/s12017-013-8232-3"/>
</citation>
<scope>INTERACTION WITH MARK1; MARK2; MARK3 AND MARK4</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-579</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-519</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2016" name="Mol. Neurobiol." volume="53" first="3124" last="3135">
<title>LRRK2 Promotes Tau Accumulation, Aggregation and Release.</title>
<authorList>
<person name="Guerreiro P.S."/>
<person name="Gerhardt E."/>
<person name="Lopes da Fonseca T."/>
<person name="Baehr M."/>
<person name="Outeiro T.F."/>
<person name="Eckermann K."/>
</authorList>
<dbReference type="PubMed" id="26014385"/>
<dbReference type="DOI" id="10.1007/s12035-015-9209-z"/>
</citation>
<scope>INTERACTION WITH LRRK2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2020" name="Nature">
<title>LRP1 is a master regulator of tau uptake and spread.</title>
<authorList>
<person name="Rauch J.N."/>
<person name="Luna G."/>
<person name="Guzman E."/>
<person name="Challis C."/>
<person name="Sibih Y.E."/>
<person name="Leshuk C."/>
<person name="Hernandez I."/>
<person name="Wegmann S."/>
<person name="Hyman B.T."/>
<person name="Gradinaru V."/>
<person name="Kampmann M."/>
<person name="Kosik K.S."/>
</authorList>
<dbReference type="PubMed" id="32296178"/>
<dbReference type="DOI" id="10.1038/s41586-020-2156-5"/>
</citation>
<scope>INTERACTION WITH LRP1</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="25150" last="25156">
<title>1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides.</title>
<authorList>
<person name="Wintjens R."/>
<person name="Wieruszeski J.-M."/>
<person name="Drobecq H."/>
<person name="Rousselot-Pailley P."/>
<person name="Buee L."/>
<person name="Lippens G."/>
<person name="Landrieu I."/>
</authorList>
<dbReference type="PubMed" id="11313338"/>
<dbReference type="DOI" id="10.1074/jbc.m010327200"/>
</citation>
<scope>STRUCTURE BY NMR OF 542-554 IN COMPLEX WITH PIN1</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2020" name="Cell" volume="181" first="637" last="652">
<title>A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion.</title>
<authorList>
<person name="Zhang M."/>
<person name="Liu L."/>
<person name="Lin X."/>
<person name="Wang Y."/>
<person name="Li Y."/>
<person name="Guo Q."/>
<person name="Li S."/>
<person name="Sun Y."/>
<person name="Tao X."/>
<person name="Zhang D."/>
<person name="Lv X."/>
<person name="Zheng L."/>
<person name="Ge L."/>
</authorList>
<dbReference type="PubMed" id="32272059"/>
<dbReference type="DOI" id="10.1016/j.cell.2020.03.031"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2000" name="Biochim. Biophys. Acta" volume="1502" first="110" last="121">
<title>Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.</title>
<authorList>
<person name="Goedert M."/>
<person name="Spillantini M.G."/>
</authorList>
<dbReference type="PubMed" id="10899436"/>
<dbReference type="DOI" id="10.1016/s0925-4439(00)00037-5"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1998" name="Ann. Neurol." volume="43" first="815" last="825">
<title>Tau is a candidate gene for chromosome 17 frontotemporal dementia.</title>
<authorList>
<person name="Poorkaj P."/>
<person name="Bird T.D."/>
<person name="Wijsman E."/>
<person name="Nemens E."/>
<person name="Garruto R.M."/>
<person name="Anderson L."/>
<person name="Andreadis A."/>
<person name="Wiederholt W.C."/>
<person name="Raskind M."/>
<person name="Schellenberg G.D."/>
</authorList>
<dbReference type="PubMed" id="9629852"/>
<dbReference type="DOI" id="10.1002/ana.410430617"/>
</citation>
<scope>VARIANT FTD MET-654</scope>
<scope>VARIANTS ASN-285; ALA-289; HIS-441 AND PRO-447</scope>
<scope>INVOLVEMENT IN FTD</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1998" name="Ann. Neurol." volume="44" first="428" last="428">
<authorList>
<person name="Poorkaj P."/>
<person name="Bird T.D."/>
<person name="Wijsman E."/>
<person name="Nemens E."/>
<person name="Garruto R.M."/>
<person name="Anderson L."/>
<person name="Andreadis A."/>
<person name="Wiederholt W.C."/>
<person name="Raskind M."/>
<person name="Schellenberg G.D."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:9629852</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="1825" last="1829">
<title>Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism.</title>
<authorList>
<person name="Dumanchin C."/>
<person name="Camuzat A."/>
<person name="Campion D."/>
<person name="Verpillat P."/>
<person name="Hannequin D."/>
<person name="Dubois B."/>
<person name="Saugier-Veber P."/>
<person name="Martin C."/>
<person name="Penet C."/>
<person name="Charbonnier F."/>
<person name="Agid Y."/>
<person name="Frebourg T."/>
<person name="Brice A."/>
</authorList>
<dbReference type="PubMed" id="9736786"/>
<dbReference type="DOI" id="10.1093/hmg/7.11.1825"/>
</citation>
<scope>VARIANT FTD LEU-618</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1998" name="Nature" volume="393" first="702" last="705">
<title>Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.</title>
<authorList>
<person name="Hutton M."/>
<person name="Lendon C.L."/>
<person name="Rizzu P."/>
<person name="Baker M."/>
<person name="Froelich S."/>
<person name="Houlden H."/>
<person name="Pickering-Brown S."/>
<person name="Chakraverty S."/>
<person name="Isaacs A."/>
<person name="Grover A."/>
<person name="Hackett J."/>
<person name="Adamson J."/>
<person name="Lincoln S."/>
<person name="Dickson D."/>
<person name="Davies P."/>
<person name="Petersen R.C."/>
<person name="Stevens M."/>
<person name="de Graaff E."/>
<person name="Wauters E."/>
<person name="van Baren J."/>
<person name="Hillebrand M."/>
<person name="Joosse M."/>
<person name="Kwon J.M."/>
<person name="Nowotny P."/>
<person name="Che L.K."/>
<person name="Norton J."/>
<person name="Morris J.C."/>
<person name="Reed L.A."/>
<person name="Trojanowski J."/>
<person name="Basun H."/>
<person name="Lannfelt L."/>
<person name="Neystat M."/>
<person name="Fahn S."/>
<person name="Dark F."/>
<person name="Tannenberg T."/>
<person name="Dodd P.R."/>
<person name="Hayward N."/>
<person name="Kwok J.B.J."/>
<person name="Schofield P.R."/>
<person name="Andreadis A."/>
<person name="Snowden J."/>
<person name="Craufurd D."/>
<person name="Neary D."/>
<person name="Owen F."/>
<person name="Oostra B.A."/>
<person name="Hardy J."/>
<person name="Goate A."/>
<person name="van Swieten J."/>
<person name="Mann D."/>
<person name="Lynch T."/>
<person name="Heutink P."/>
</authorList>
<dbReference type="PubMed" id="9641683"/>
<dbReference type="DOI" id="10.1038/31508"/>
</citation>
<scope>VARIANTS FTD VAL-589; LEU-618 AND TRP-723</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="13103" last="13107">
<title>Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.</title>
<authorList>
<person name="Clark L.N."/>
<person name="Poorkaj P."/>
<person name="Wszolek Z."/>
<person name="Geschwind D.H."/>
<person name="Nasreddine Z.S."/>
<person name="Miller B."/>
<person name="Li D."/>
<person name="Payami H."/>
<person name="Awert F."/>
<person name="Markopoulou K."/>
<person name="Andreadis A."/>
<person name="D'Souza I."/>
<person name="Lee V.M.-Y."/>
<person name="Reed L."/>
<person name="Trojanowski J.Q."/>
<person name="Zhukareva V."/>
<person name="Bird T."/>
<person name="Schellenberg G."/>
<person name="Wilhelmsen K.C."/>
</authorList>
<dbReference type="PubMed" id="9789048"/>
<dbReference type="DOI" id="10.1073/pnas.95.22.13103"/>
</citation>
<scope>VARIANTS FTD LYS-596 AND LEU-618</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1999" name="Acta Neuropathol." volume="98" first="62" last="77">
<title>A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.</title>
<authorList>
<person name="Delisle M.-B."/>
<person name="Murrell J.R."/>
<person name="Richardson R."/>
<person name="Trofatter J.A."/>
<person name="Rascol O."/>
<person name="Soulages X."/>
<person name="Mohr M."/>
<person name="Calvas P."/>
<person name="Ghetti B."/>
</authorList>
<dbReference type="PubMed" id="10412802"/>
<dbReference type="DOI" id="10.1007/s004010051052"/>
</citation>
<scope>VARIANT PPND LYS-596</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="64" first="414" last="421">
<title>High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.</title>
<authorList>
<person name="Rizzu P."/>
<person name="Van Swieten J.C."/>
<person name="Joosse M."/>
<person name="Hasegawa M."/>
<person name="Stevens M."/>
<person name="Tibben A."/>
<person name="Niermeijer M.F."/>
<person name="Hillebrand M."/>
<person name="Ravid R."/>
<person name="Oostra B.A."/>
<person name="Goedert M."/>
<person name="van Duijn C.M."/>
<person name="Heutink P."/>
</authorList>
<dbReference type="PubMed" id="9973279"/>
<dbReference type="DOI" id="10.1086/302256"/>
</citation>
<scope>VARIANTS FTD VAL-589; LYS-597 DEL; LEU-618 AND TRP-723</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1999" name="Ann. Neurol." volume="46" first="708" last="715">
<title>FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation.</title>
<authorList>
<person name="Sperfeld A.D."/>
<person name="Collatz M.B."/>
<person name="Baier H."/>
<person name="Palmbach M."/>
<person name="Storch A."/>
<person name="Schwarz J."/>
<person name="Tatsch K."/>
<person name="Reske S."/>
<person name="Joosse M."/>
<person name="Heutink P."/>
<person name="Ludolph A.C."/>
</authorList>
<dbReference type="PubMed" id="10553987"/>
<dbReference type="DOI" id="10.1002/1531-8249(199911)46:5&lt;708::aid-ana5&gt;3.0.co;2-k"/>
</citation>
<scope>VARIANT FTD SER-618</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1999" name="FEBS Lett." volume="447" first="195" last="199">
<title>Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.</title>
<authorList>
<person name="Nacharaju P."/>
<person name="Lewis J."/>
<person name="Easson C."/>
<person name="Yen S."/>
<person name="Hackett J."/>
<person name="Hutton M."/>
<person name="Yen S.H."/>
</authorList>
<dbReference type="PubMed" id="10214944"/>
<dbReference type="DOI" id="10.1016/s0014-5793(99)00294-x"/>
</citation>
<scope>VARIANTS FTD LEU-618; MET-654 AND TRP-723</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1999" name="J. Neuropathol. Exp. Neurol." volume="58" first="667" last="677">
<title>Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.</title>
<authorList>
<person name="Bugiani O."/>
<person name="Murrell J.R."/>
<person name="Giaccone G."/>
<person name="Hasegawa M."/>
<person name="Ghigo G."/>
<person name="Tabaton M."/>
<person name="Morbin M."/>
<person name="Primavera A."/>
<person name="Carella F."/>
<person name="Solaro C."/>
<person name="Grisoli M."/>
<person name="Savoiardo M."/>
<person name="Spillantini M.G."/>
<person name="Tagliavini F."/>
<person name="Goedert M."/>
<person name="Ghetti B."/>
</authorList>
<dbReference type="PubMed" id="10374757"/>
<dbReference type="DOI" id="10.1097/00005072-199906000-00011"/>
</citation>
<scope>VARIANT FTD/CBD SER-618</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1999" name="J. Neuropathol. Exp. Neurol." volume="58" first="1207" last="1226">
<title>Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits.</title>
<authorList>
<person name="Murrell J.R."/>
<person name="Spillantini M.G."/>
<person name="Zolo P."/>
<person name="Guazzelli M."/>
<person name="Smith M.J."/>
<person name="Hasegawa M."/>
<person name="Redi F."/>
<person name="Crowther R.A."/>
<person name="Pietrini P."/>
<person name="Ghetti B."/>
<person name="Goedert M."/>
</authorList>
<dbReference type="PubMed" id="10604746"/>
<dbReference type="DOI" id="10.1097/00005072-199912000-00002"/>
</citation>
<scope>VARIANT PIDB ARG-706</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1999" name="Neurology" volume="53" first="864" last="868">
<title>A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration.</title>
<authorList>
<person name="Yasuda M."/>
<person name="Kawamata T."/>
<person name="Komure O."/>
<person name="Kuno S."/>
<person name="D'Souza I."/>
<person name="Poorkaj P."/>
<person name="Kawai J."/>
<person name="Tanimukai S."/>
<person name="Yamamoto Y."/>
<person name="Hasegawa H."/>
<person name="Sasahara M."/>
<person name="Hazama F."/>
<person name="Schellenberg G.D."/>
<person name="Tanaka C."/>
</authorList>
<dbReference type="PubMed" id="10489057"/>
<dbReference type="DOI" id="10.1212/wnl.53.4.864"/>
</citation>
<scope>VARIANT FTD LYS-596</scope>
</reference>
<reference key="63">
<citation type="journal article" date="1999" name="Neurology" volume="53" first="1421" last="1424">
<title>Mutational analysis of the tau gene in progressive supranuclear palsy.</title>
<authorList>
<person name="Higgins J.J."/>
<person name="Adler R.L."/>
<person name="Loveless J.M."/>
</authorList>
<dbReference type="PubMed" id="10534245"/>
<dbReference type="DOI" id="10.1212/wnl.53.7.1421"/>
</citation>
<scope>VARIANTS PSNP1 ASN-285 AND ALA-289</scope>
</reference>
<reference key="64">
<citation type="journal article" date="1999" name="NeuroReport" volume="10" first="497" last="501">
<title>A distinct familial presenile dementia with a novel missense mutation in the tau gene.</title>
<authorList>
<person name="Iijima M."/>
<person name="Tabira T."/>
<person name="Poorkaj P."/>
<person name="Schellenberg G.D."/>
<person name="Trojanowski J.Q."/>
<person name="Lee V.M.-Y."/>
<person name="Schmidt M.L."/>
<person name="Takahashi K."/>
<person name="Nabika T."/>
<person name="Matsumoto T."/>
<person name="Yamashita Y."/>
<person name="Yoshioka S."/>
<person name="Ishino H."/>
</authorList>
<dbReference type="PubMed" id="10208578"/>
<dbReference type="DOI" id="10.1097/00001756-199902250-00010"/>
</citation>
<scope>VARIANT FTD ASN-622</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2000" name="Ann. Neurol." volume="48" first="850" last="858">
<title>Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation.</title>
<authorList>
<person name="Lippa C.F."/>
<person name="Zhukareva V."/>
<person name="Kawarai T."/>
<person name="Uryu K."/>
<person name="Shafiq M."/>
<person name="Nee L.E."/>
<person name="Grafman J."/>
<person name="Liang Y."/>
<person name="St George-Hyslop P.H."/>
<person name="Trojanowski J.Q."/>
<person name="Lee V.M.-Y."/>
</authorList>
<dbReference type="PubMed" id="11117541"/>
<dbReference type="DOI" id="10.1002/1531-8249(200012)48:6&lt;850::aid-ana5&gt;3.0.co;2-v"/>
</citation>
<scope>VARIANT FTD VAL-659</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2000" name="Ann. Neurol." volume="48" first="859" last="867">
<title>Pick's disease is associated with mutations in the tau gene.</title>
<authorList>
<person name="Pickering-Brown S."/>
<person name="Baker M."/>
<person name="Yen S.-H."/>
<person name="Liu W.-K."/>
<person name="Hasegawa M."/>
<person name="Cairns N."/>
<person name="Lantos P.L."/>
<person name="Rossor M."/>
<person name="Iwatsubo T."/>
<person name="Davies Y."/>
<person name="Allsop D."/>
<person name="Furlong R."/>
<person name="Owen F."/>
<person name="Hardy J."/>
<person name="Mann D."/>
<person name="Hutton M."/>
</authorList>
<dbReference type="PubMed" id="11117542"/>
<dbReference type="DOI" id="10.1002/1531-8249(200012)48:6&lt;859::aid-ana6&gt;3.0.co;2-1"/>
</citation>
<scope>VARIANTS PIDB THR-574 AND ARG-706</scope>
<scope>CHARACTERIZATION OF VARIANTS PIDB THR-574 AND ARG-706</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2000" name="J. Neuropathol. Exp. Neurol." volume="59" first="990" last="1001">
<title>Tau gene mutation K257T causes a tauopathy similar to Pick's disease.</title>
<authorList>
<person name="Rizzini C."/>
<person name="Goedert M."/>
<person name="Hodges J.R."/>
<person name="Smith M.J."/>
<person name="Jakes R."/>
<person name="Hills R."/>
<person name="Xuereb J.H."/>
<person name="Crowther R.A."/>
<person name="Spillantini M.G."/>
</authorList>
<dbReference type="PubMed" id="11089577"/>
<dbReference type="DOI" id="10.1093/jnen/59.11.990"/>
</citation>
<scope>VARIANT PIDB THR-574</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2000" name="Neurology" volume="54" first="1787" last="1795">
<title>Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene.</title>
<authorList>
<person name="Arima K."/>
<person name="Kowalska A."/>
<person name="Hasegawa M."/>
<person name="Mukoyama M."/>
<person name="Watanabe R."/>
<person name="Kawai M."/>
<person name="Takahashi K."/>
<person name="Iwatsubo T."/>
<person name="Tabira T."/>
<person name="Sunohara N."/>
</authorList>
<dbReference type="PubMed" id="10802785"/>
<dbReference type="DOI" id="10.1212/wnl.54.9.1787"/>
</citation>
<scope>VARIANT FTD LYS-596</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2000" name="Neurology" volume="55" first="1224" last="1227">
<title>A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation.</title>
<authorList>
<person name="Yasuda M."/>
<person name="Yokoyama K."/>
<person name="Nakayasu T."/>
<person name="Nishimura Y."/>
<person name="Matsui M."/>
<person name="Yokoyama T."/>
<person name="Miyoshi K."/>
<person name="Tanaka C."/>
</authorList>
<dbReference type="PubMed" id="11071507"/>
<dbReference type="DOI" id="10.1212/wnl.55.8.1224"/>
</citation>
<scope>VARIANT FTD SER-618</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2001" name="Acta Neuropathol." volume="102" first="285" last="292">
<title>Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells.</title>
<authorList>
<person name="Iseki E."/>
<person name="Matsumura T."/>
<person name="Marui W."/>
<person name="Hino H."/>
<person name="Odawara T."/>
<person name="Sugiyama N."/>
<person name="Suzuki K."/>
<person name="Sawada H."/>
<person name="Arai T."/>
<person name="Kosaka K."/>
</authorList>
<dbReference type="PubMed" id="11585254"/>
<dbReference type="DOI" id="10.1007/s004010000333"/>
</citation>
<scope>VARIANT FTD HIS-613</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2001" name="Ann. Neurol." volume="49" first="263" last="267">
<title>Familial atypical progressive supranuclear palsy associated with homozygosity for the delN296 mutation in the tau gene.</title>
<authorList>
<person name="Pastor P."/>
<person name="Pastor E."/>
<person name="Carnero C."/>
<person name="Vela R."/>
<person name="Garcia T."/>
<person name="Amer G."/>
<person name="Tolosa E."/>
<person name="Oliva R."/>
</authorList>
<dbReference type="PubMed" id="11220749"/>
<dbReference type="DOI" id="10.1002/1531-8249(20010201)49:2&lt;263::aid-ana50&gt;3.0.co;2-k"/>
</citation>
<scope>VARIANT PSNP1 ASN-613 DEL</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2001" name="Ann. Neurol." volume="50" first="503" last="513">
<title>Pick's disease associated with the novel Tau gene mutation K369I.</title>
<authorList>
<person name="Neumann M."/>
<person name="Schulz-Schaeffer W."/>
<person name="Crowther R.A."/>
<person name="Smith M.J."/>
<person name="Spillantini M.G."/>
<person name="Goedert M."/>
<person name="Kretzschmar H.A."/>
</authorList>
<dbReference type="PubMed" id="11601501"/>
<dbReference type="DOI" id="10.1002/ana.1223"/>
</citation>
<scope>VARIANT PIDB ILE-686</scope>
<scope>CHARACTERIZATION OF VARIANT PIDB ILE-686</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2001" name="FEBS Lett." volume="493" first="40" last="44">
<title>Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes.</title>
<authorList>
<person name="Connell J.W."/>
<person name="Gibb G.M."/>
<person name="Betts J.C."/>
<person name="Blackstock W.P."/>
<person name="Gallo J.-M."/>
<person name="Lovestone S."/>
<person name="Hutton M."/>
<person name="Anderton B.H."/>
</authorList>
<dbReference type="PubMed" id="11278002"/>
<dbReference type="DOI" id="10.1016/s0014-5793(01)02267-0"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT FTD TRP-723</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2002" name="Neurology" volume="59" first="1791" last="1793">
<title>Clinical and genetic studies of families with the tau N279K mutation (FTDP-17).</title>
<authorList>
<person name="Tsuboi Y."/>
<person name="Baker M."/>
<person name="Hutton M.L."/>
<person name="Uitti R.J."/>
<person name="Rascol O."/>
<person name="Delisle M.-B."/>
<person name="Soulages X."/>
<person name="Murrell J.R."/>
<person name="Ghetti B."/>
<person name="Yasuda M."/>
<person name="Komure O."/>
<person name="Kuno S."/>
<person name="Arima K."/>
<person name="Sunohara N."/>
<person name="Kobayashi T."/>
<person name="Mizuno Y."/>
<person name="Wszolek Z.K."/>
</authorList>
<dbReference type="PubMed" id="12473774"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000038909.49164.4b"/>
</citation>
<scope>VARIANT FTD LYS-596</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2002" name="Ann. Neurol." volume="51" first="373" last="376">
<title>A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease.</title>
<authorList>
<person name="Rosso S.M."/>
<person name="Van Herpen E."/>
<person name="Deelen W."/>
<person name="Kamphorst W."/>
<person name="Severijnen L.-A."/>
<person name="Willemsen R."/>
<person name="Ravid R."/>
<person name="Niermeijer M.F."/>
<person name="Dooijes D."/>
<person name="Smith M.J."/>
<person name="Goedert M."/>
<person name="Heutink P."/>
<person name="Van Swieten J.C."/>
</authorList>
<dbReference type="PubMed" id="11891833"/>
<dbReference type="DOI" id="10.1002/ana.10140"/>
</citation>
<scope>VARIANT PIDB PHE-637</scope>
<scope>CHARACTERIZATION OF VARIANT PIDB PHE-637</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2002" name="Ann. Neurol." volume="51" first="525" last="530">
<title>Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation.</title>
<authorList>
<person name="Hayashi S."/>
<person name="Toyoshima Y."/>
<person name="Hasegawa M."/>
<person name="Umeda Y."/>
<person name="Wakabayashi K."/>
<person name="Tokiguchi S."/>
<person name="Iwatsubo T."/>
<person name="Takahashi H."/>
</authorList>
<dbReference type="PubMed" id="11921059"/>
<dbReference type="DOI" id="10.1002/ana.10163"/>
</citation>
<scope>VARIANT FTD HIS-5</scope>
<scope>CHARACTERIZATION OF VARIANT FTD HIS-5</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2002" name="Ann. Neurol." volume="52" first="511" last="516">
<title>An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype.</title>
<authorList>
<person name="Poorkaj P."/>
<person name="Muma N.A."/>
<person name="Zhukareva V."/>
<person name="Cochran E.J."/>
<person name="Shannon K.M."/>
<person name="Hurtig H."/>
<person name="Koller W.C."/>
<person name="Bird T.D."/>
<person name="Trojanowski J.Q."/>
<person name="Lee V.M.-Y."/>
<person name="Schellenberg G.D."/>
</authorList>
<dbReference type="PubMed" id="12325083"/>
<dbReference type="DOI" id="10.1002/ana.10340"/>
</citation>
<scope>VARIANT PSNP1 LEU-5</scope>
<scope>CHARACTERIZATION OF VARIANT PSNP1 LEU-5</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2002" name="J. Neurochem." volume="80" first="548" last="551">
<title>Functional effects of tau gene mutations deltaN296 and N296H.</title>
<authorList>
<person name="Yoshida H."/>
<person name="Crowther R.A."/>
<person name="Goedert M."/>
</authorList>
<dbReference type="PubMed" id="11906000"/>
<dbReference type="DOI" id="10.1046/j.0022-3042.2001.00729.x"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS FTD ASN-613 DEL AND HIS-613</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2002" name="Neurology" volume="58" first="811" last="813">
<title>Early-onset, rapidly progressive familial tauopathy with R406W mutation.</title>
<authorList>
<person name="Saito Y."/>
<person name="Geyer A."/>
<person name="Sasaki R."/>
<person name="Kuzuhara S."/>
<person name="Nanba E."/>
<person name="Miyasaka T."/>
<person name="Suzuki K."/>
<person name="Murayama S."/>
</authorList>
<dbReference type="PubMed" id="11889249"/>
<dbReference type="DOI" id="10.1212/wnl.58.5.811"/>
</citation>
<scope>VARIANT FTD TRP-723</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2003" name="Ann. Neurol." volume="53" first="133" last="137">
<title>A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology.</title>
<authorList>
<person name="Kobayashi T."/>
<person name="Ota S."/>
<person name="Tanaka K."/>
<person name="Ito Y."/>
<person name="Hasegawa M."/>
<person name="Umeda Y."/>
<person name="Motoi Y."/>
<person name="Takanashi M."/>
<person name="Yasuhara M."/>
<person name="Anno M."/>
<person name="Mizuno Y."/>
<person name="Mori H."/>
</authorList>
<dbReference type="PubMed" id="12509859"/>
<dbReference type="DOI" id="10.1002/ana.10447"/>
</citation>
<scope>VARIANT FTD VAL-583</scope>
<scope>CHARACTERIZATION OF VARIANT FTD VAL-583</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2003" name="Ann. Neurol." volume="54" first="682" last="686">
<title>An English kindred with a novel recessive tauopathy and respiratory failure.</title>
<authorList>
<person name="Nicholl D.J."/>
<person name="Greenstone M.A."/>
<person name="Clarke C.E."/>
<person name="Rizzu P."/>
<person name="Crooks D."/>
<person name="Crowe A."/>
<person name="Trojanowski J.Q."/>
<person name="Lee V.M.-Y."/>
<person name="Heutink P."/>
</authorList>
<dbReference type="PubMed" id="14595660"/>
<dbReference type="DOI" id="10.1002/ana.10747"/>
</citation>
<scope>VARIANT FATAL RESPIRATORY HYPOVENTILATION LEU-669</scope>
<scope>CHARACTERIZATION OF VARIANT FATAL RESPIRATORY HYPOVENTILATION LEU-669</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="22" first="409" last="411">
<title>Tau (MAPT) mutation arg406trp presenting clinically with Alzheimer disease does not share a common founder in western Europe.</title>
<authorList>
<person name="Rademakers R."/>
<person name="Dermaut B."/>
<person name="Peeters K."/>
<person name="Cruts M."/>
<person name="Heutink P."/>
<person name="Goate A."/>
<person name="Van Broeckhoven C."/>
</authorList>
<dbReference type="PubMed" id="14517953"/>
<dbReference type="DOI" id="10.1002/humu.10269"/>
</citation>
<scope>VARIANT FTD/ALZHEIMER DISEASE TRP-723</scope>
<scope>INVOLVEMENT IN ALZHEIMER DISEASE</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2004" name="Ann. Neurol." volume="55" first="448" last="448">
<title>Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene.</title>
<authorList>
<person name="Rossi G."/>
<person name="Gasparoli E."/>
<person name="Pasquali C."/>
<person name="Di Fede G."/>
<person name="Testa D."/>
<person name="Albanese A."/>
<person name="Bracco F."/>
<person name="Tagliavini F."/>
</authorList>
<dbReference type="PubMed" id="14991829"/>
<dbReference type="DOI" id="10.1002/ana.20006"/>
</citation>
<scope>VARIANT ATYPICAL PSNP1 ASN-613 DEL</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2004" name="Ann. Neurol." volume="55" first="448" last="449">
<title>Tau gene delN296 mutation, Parkinson's disease, and atypical supranuclear palsy.</title>
<authorList>
<person name="Oliva R."/>
<person name="Pastor P."/>
</authorList>
<dbReference type="PubMed" id="14991828"/>
<dbReference type="DOI" id="10.1002/ana.20025"/>
</citation>
<scope>VARIANT PSNP1/ATYPICAL PSNP1 ASN-613 DEL</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2005" name="Ann. Neurol." volume="58" first="920" last="928">
<title>Phenotypic heterogeneity within a new family with the MAPT P301S mutation.</title>
<authorList>
<person name="Yasuda M."/>
<person name="Nakamura Y."/>
<person name="Kawamata T."/>
<person name="Kaneyuki H."/>
<person name="Maeda K."/>
<person name="Komure O."/>
</authorList>
<dbReference type="PubMed" id="16240366"/>
<dbReference type="DOI" id="10.1002/ana.20668"/>
</citation>
<scope>VARIANT FTD SER-618</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2005" name="Arch. Neurol." volume="62" first="1444" last="1450">
<title>A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.</title>
<authorList>
<person name="Ros R."/>
<person name="Thobois S."/>
<person name="Streichenberger N."/>
<person name="Kopp N."/>
<person name="Sanchez M.P."/>
<person name="Perez M."/>
<person name="Hoenicka J."/>
<person name="Avila J."/>
<person name="Honnorat J."/>
<person name="de Yebenes J.G."/>
</authorList>
<dbReference type="PubMed" id="16157753"/>
<dbReference type="DOI" id="10.1001/archneur.62.9.1444"/>
</citation>
<scope>VARIANT PSNP1 VAL-620</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2005" name="Neurology" volume="64" first="1578" last="1585">
<title>A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease.</title>
<authorList>
<person name="Zarranz J.J."/>
<person name="Ferrer I."/>
<person name="Lezcano E."/>
<person name="Forcadas M.I."/>
<person name="Eizaguirre B."/>
<person name="Atares B."/>
<person name="Puig B."/>
<person name="Gomez-Esteban J.C."/>
<person name="Fernandez-Maiztegui C."/>
<person name="Rouco I."/>
<person name="Perez-Concha T."/>
<person name="Fernandez M."/>
<person name="Rodriguez O."/>
<person name="Rodriguez-Martinez A.B."/>
<person name="de Pancorbo M.M."/>
<person name="Pastor P."/>
<person name="Perez-Tur J."/>
</authorList>
<dbReference type="PubMed" id="15883319"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000160116.65034.12"/>
</citation>
<scope>VARIANT FTD MET-634</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="E1126" last="E1140">
<title>A thorough assessment of benign genetic variability in GRN and MAPT.</title>
<authorList>
<person name="Guerreiro R.J."/>
<person name="Washecka N."/>
<person name="Hardy J."/>
<person name="Singleton A."/>
</authorList>
<dbReference type="PubMed" id="20020531"/>
<dbReference type="DOI" id="10.1002/humu.21152"/>
</citation>
<scope>VARIANTS MET-17; ALA-30 AND ILE-617</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2015" name="Gene" volume="570" first="150" last="152">
<title>Homozygous MAPT R406W mutation causing FTDP phenotype: A unique instance of a unique mutation.</title>
<authorList>
<person name="Behnam M."/>
<person name="Ghorbani F."/>
<person name="Shin J.H."/>
<person name="Kim D.S."/>
<person name="Jang H."/>
<person name="Nouri N."/>
<person name="Sedghi M."/>
<person name="Salehi M."/>
<person name="Ansari B."/>
<person name="Basiri K."/>
</authorList>
<dbReference type="PubMed" id="26086902"/>
<dbReference type="DOI" id="10.1016/j.gene.2015.06.033"/>
</citation>
<scope>VARIANT FTD/ALZHEIMER DISEASE TRP-723</scope>
</reference>
<comment type="function">
<text evidence="69">Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.</text>
</comment>
<comment type="subunit">
<text evidence="16 17 35 49 57 62 66 70 71 74">Interacts with MARK1, MARK2, MARK3 AND MARK4 (PubMed:23666762). Interacts with PSMC2 through SQSTM1 (By similarity). Interacts with SQSTM1 when polyubiquitinated (PubMed:15953362). Interacts with FKBP4 (By similarity). Binds to CSNK1D (PubMed:14761950). Interacts with SGK1 (PubMed:16982696). Interacts with EPM2A; the interaction dephosphorylates MAPT at Ser-396 (PubMed:19542233). Interacts with PIN1 (PubMed:11313338). Interacts with LRRK2 (PubMed:26014385). Interacts with LRP1, leading to endocytosis; this interaction is reduced in the presence of LRPAP1/RAP (PubMed:32296178).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-9209835">
<id>PRO_0000001987</id>
<label>APOE</label>
<dbReference type="UniProtKB" id="P02649"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-77613">
<id>P05067</id>
<label>APP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-821758">
<id>PRO_0000000092</id>
<label>APP</label>
<dbReference type="UniProtKB" id="P05067"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-351896">
<id>P11142</id>
<label>HSPA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-726739">
<id>Q9UPY8</id>
<label>MAPRE3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-366182">
<id>P10636</id>
<label>MAPT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-516560">
<id>Q7KZI7</id>
<label>MARK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-977302">
<id>P04156</id>
<label>PRNP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-366357">
<id>P46779</id>
<label>RPL28</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-3440986">
<id>P43004</id>
<label>SLC1A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-357085">
<id>Q9UNE7</id>
<label>STUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-15687717">
<id>Q9UNE7-1</id>
<label>STUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366182">
<id>P10636</id>
</interactant>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7796412">
<id>P10636-2</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7796412">
<id>P10636-2</id>
</interactant>
<interactant intactId="EBI-5323863">
<id>Q5S007</id>
<label>LRRK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7796412">
<id>P10636-2</id>
</interactant>
<interactant intactId="EBI-476295">
<id>P31947</id>
<label>SFN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7796412">
<id>P10636-2</id>
</interactant>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7145070">
<id>P10636-3</id>
</interactant>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-21313635">
<id>P10636-5</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7796455">
<id>P10636-6</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7796455">
<id>P10636-6</id>
</interactant>
<interactant intactId="EBI-351896">
<id>P11142</id>
<label>HSPA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6926270">
<id>P10636-7</id>
</interactant>
<interactant intactId="EBI-6926280">
<id>O00499-1</id>
<label>BIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-352622">
<id>P07355</id>
<label>ANXA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-352541">
<id>P08133</id>
<label>ANXA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-6926280">
<id>O00499-1</id>
<label>BIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-724352">
<id>Q14203</id>
<label>DCTN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-351257">
<id>P26196</id>
<label>DDX6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-306914">
<id>Q13451</id>
<label>FKBP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-352256">
<id>Q92743</id>
<label>HTRA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-5323863">
<id>Q5S007</id>
<label>LRRK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-366233">
<id>P10636-8</id>
<label>MAPT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-516560">
<id>Q7KZI7</id>
<label>MARK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-726515">
<id>O43347</id>
<label>MSI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-2462339">
<id>Q96DH6</id>
<label>MSI2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-985879">
<id>P37840</id>
<label>SNCA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366233">
<id>P10636-8</id>
</interactant>
<interactant intactId="EBI-302552">
<id>Q71U36</id>
<label>TUBA1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="27 70 71">Cytoplasm</location>
<location evidence="27 70 71">Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="27">Cell membrane</location>
<topology evidence="27">Peripheral membrane protein</topology>
<orientation evidence="27">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="27">Cytoplasm</location>
<location evidence="27">Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="27">Cell projection</location>
<location evidence="27">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="70">Cell projection</location>
<location evidence="70">Dendrite</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="73">Secreted</location>
</subcellularLocation>
<text evidence="27 73">Mostly found in the axons of neurons, in the cytosol and in association with plasma membrane components (PubMed:10747907). Can be secreted; the secretion is dependent on protein unfolding and facilitated by the cargo receptor TMED10; it results in protein translocation from the cytoplasm into the ERGIC (endoplasmic reticulum-Golgi intermediate compartment) followed by vesicle entry and secretion (PubMed:32272059).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P10636-1</id>
<name>PNS-tau</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P10636-2</id>
<name>Fetal-tau</name>
<name evidence="89">0N3R</name>
<sequence type="described" ref="VSP_003176 VSP_003177 VSP_003179 VSP_003180 VSP_003181"/>
</isoform>
<isoform>
<id>P10636-3</id>
<name>Tau-A</name>
<sequence type="described" ref="VSP_003175 VSP_003176 VSP_003177 VSP_003178 VSP_003179 VSP_003180 VSP_003181"/>
</isoform>
<isoform>
<id>P10636-4</id>
<name>Tau-B</name>
<name evidence="89">1N3R</name>
<sequence type="described" ref="VSP_003177 VSP_003179 VSP_003180 VSP_003181"/>
</isoform>
<isoform>
<id>P10636-5</id>
<name>Tau-C</name>
<name>Tau-3</name>
<name evidence="89">2N3R</name>
<sequence type="described" ref="VSP_003179 VSP_003180 VSP_003181"/>
</isoform>
<isoform>
<id>P10636-6</id>
<name>Tau-D</name>
<name evidence="89">0N4R</name>
<sequence type="described" ref="VSP_003176 VSP_003177 VSP_003179 VSP_003180"/>
</isoform>
<isoform>
<id>P10636-7</id>
<name>Tau-E</name>
<name evidence="89">1N4R</name>
<sequence type="described" ref="VSP_003177 VSP_003179 VSP_003180"/>
</isoform>
<isoform>
<id>P10636-8</id>
<name>Tau-F</name>
<name>Tau-4</name>
<name evidence="89">2N4R</name>
<sequence type="described" ref="VSP_003179 VSP_003180"/>
</isoform>
<isoform>
<id>P10636-9</id>
<name>Tau-G</name>
<sequence type="described" ref="VSP_026780"/>
</isoform>
<text>Additional isoforms seem to exist. Isoforms differ from each other by the presence or absence of up to 5 of the 15 exons. One of these optional exons contains the additional tau/MAP repeat.</text>
</comment>
<comment type="tissue specificity">
<text>Expressed in neurons. Isoform PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system.</text>
</comment>
<comment type="developmental stage">
<text>Four-repeat (type II) TAU/MAPT is expressed in an adult-specific manner and is not found in fetal brain, whereas three-repeat (type I) TAU/MAPT is found in both adult and fetal brain.</text>
</comment>
<comment type="domain">
<text>The tau/MAP repeat binds to tubulin. Type I isoforms contain 3 repeats while type II isoforms contain 4 repeats.</text>
</comment>
<comment type="PTM">
<text evidence="48 49 55 60 62 65 68 69 70 75 76 78">Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1, CDK1, CDK5, GSK3, MAPK) (only 2-3 sites per protein in interphase, seven-fold increase in mitosis, and in the form associated with paired helical filaments (PHF-tau)), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1, MARK2, MARK3 or MARK4), causing detachment from microtubules, and their disassembly (PubMed:7706316, PubMed:23666762). Phosphorylation decreases with age. Phosphorylation within tau/MAP's repeat domain or in flanking regions seems to reduce tau/MAP's interaction with, respectively, microtubules or plasma membrane components (PubMed:7706316). Phosphorylation on Ser-610, Ser-622, Ser-641 and Ser-673 in several isoforms during mitosis. Phosphorylation at Ser-548 by GSK3B reduces ability to bind and stabilize microtubules. Phosphorylation at Ser-579 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylated at Ser-554, Ser-579, Ser-602, Ser-606 and Ser-669 by PHK. Phosphorylation at Ser-214 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons. There is a reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces glycosylation by a factor of 2 and 4 respectively. Phosphorylation on Ser-721 is reduced by about 41.5% by GlcNAcylation on Ser-717. Dephosphorylated at several serine and threonine residues by the serine/threonine phosphatase PPP5C.</text>
</comment>
<comment type="PTM">
<text evidence="15 57 60">Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome (By similarity). PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.</text>
</comment>
<comment type="PTM">
<text evidence="49 55 60 65 68 78">O-glycosylated. O-GlcNAcylation content is around 8.2%. There is reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces O-GlcNAcylation by a factor of 2 and 4 respectively. O-GlcNAcylation on Ser-717 decreases the phosphorylation on Ser-721 by about 41.5%.</text>
</comment>
<comment type="PTM">
<text>Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle formation in AD.</text>
</comment>
<comment type="disease">
<text evidence="46 72">In Alzheimer disease, the neuronal cytoskeleton in the brain is progressively disrupted and replaced by tangles of paired helical filaments (PHF) and straight filaments, mainly composed of hyperphosphorylated forms of TAU (PHF-TAU or AD P-TAU). O-GlcNAcylation is greatly reduced in Alzheimer disease brain cerebral cortex leading to an increase in TAU/MAPT phosphorylations.</text>
</comment>
<comment type="disease" evidence="19 20 21 23 25 28 29 31 34 36 38 40 41 43 44 46 56 59 72 79 80 81 82 83">
<disease id="DI-01632">
<name>Frontotemporal dementia</name>
<acronym>FTD</acronym>
<description>A form of dementia characterized by pathologic finding of frontotemporal lobar degeneration, presenile dementia with behavioral changes, deterioration of cognitive capacities and loss of memory. In some cases, parkinsonian symptoms are prominent. Neuropathological changes include frontotemporal atrophy often associated with atrophy of the basal ganglia, substantia nigra, amygdala. In most cases, protein tau deposits are found in glial cells and/or neurons.</description>
<dbReference type="MIM" id="600274"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="26 30 32 37 39">
<disease id="DI-02937">
<name>Pick disease of the brain</name>
<acronym>PIDB</acronym>
<description>A rare form of dementia pathologically defined by severe atrophy, neuronal loss and gliosis. It is characterized by the occurrence of tau-positive inclusions, swollen neurons (Pick cells) and argentophilic neuronal inclusions known as Pick bodies that disproportionally affect the frontal and temporal cortical regions. Clinical features include aphasia, apraxia, confusion, anomia, memory loss and personality deterioration.</description>
<dbReference type="MIM" id="172700"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>Defects in MAPT are a cause of corticobasal degeneration (CBD). It is marked by extrapyramidal signs and apraxia and can be associated with memory loss. Neuropathologic features may overlap Alzheimer disease, progressive supranuclear palsy, and Parkinson disease.</text>
</comment>
<comment type="disease" evidence="24 33 42 50 51 58">
<disease id="DI-02215">
<name>Progressive supranuclear palsy 1</name>
<acronym>PSNP1</acronym>
<description>Characterized by akinetic-rigid syndrome, supranuclear gaze palsy, pyramidal tract dysfunction, pseudobulbar signs and cognitive capacities deterioration. Neurofibrillary tangles and gliosis but no amyloid plaques are found in diseased brains. Most cases appear to be sporadic, with a significant association with a common haplotype including the MAPT gene and the flanking regions. Familial cases show an autosomal dominant pattern of transmission with incomplete penetrance; genetic analysis of a few cases showed the occurrence of tau mutations, including a deletion of Asn-613.</description>
<dbReference type="MIM" id="601104"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-03096">
<name>Parkinson-dementia syndrome</name>
<acronym>PARDE</acronym>
<description>A syndrome characterized by parkinsonism, tremor, rigidity, dementia, ophthalmoparesis and pyramidal signs. Neurofibrillary degeneration occurs in the hippocampus, basal ganglia and brainstem nuclei.</description>
<dbReference type="MIM" id="260540"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Alzforum">
<link uri="https://www.alzforum.org/mutations/search?genes%255B%255D=348"/>
<text>MAPT mutations</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="https://web.expasy.org/spotlight/back_issues/068"/>
<text>Vita minima - Issue 68 of March 2006</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Tau_protein"/>
<text>Tau protein entry</text>
</comment>
<dbReference type="EMBL" id="J03778">
<property type="protein sequence ID" value="AAA60615.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X14474">
<property type="protein sequence ID" value="CAA32636.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047863">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027491">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047856">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047857">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027492">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047858">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027493">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047859">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047860">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047862">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027494">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027495">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027496">
<property type="protein sequence ID" value="AAC04277.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027491">
<property type="protein sequence ID" value="AAC04278.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027492">
<property type="protein sequence ID" value="AAC04278.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027493">
<property type="protein sequence ID" value="AAC04278.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047860">
<property type="protein sequence ID" value="AAC04278.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047862">
<property type="protein sequence ID" value="AAC04278.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027495">
<property type="protein sequence ID" value="AAC04278.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027496">
<property type="protein sequence ID" value="AAC04278.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047863">
<property type="protein sequence ID" value="AAC04278.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027491">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047856">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047857">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027492">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027493">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047860">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047862">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027494">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027495">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027496">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047863">
<property type="protein sequence ID" value="AAC04279.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF047861">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY730549">
<property type="protein sequence ID" value="AAU45390.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT006772">
<property type="protein sequence ID" value="AAP35418.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004139">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC010792">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC217771">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC217779">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000558">
<property type="protein sequence ID" value="AAH00558.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098281">
<property type="protein sequence ID" value="AAH98281.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC099721">
<property type="protein sequence ID" value="AAH99721.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC101936">
<property type="protein sequence ID" value="AAI01937.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC114504">
<property type="protein sequence ID" value="AAI14505.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC114948">
<property type="protein sequence ID" value="AAI14949.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY526356">
<property type="protein sequence ID" value="AAS17881.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M25298">
<property type="protein sequence ID" value="AAA57264.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BN000503">
<property type="protein sequence ID" value="CAG26750.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11499.1">
<molecule id="P10636-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11500.1">
<molecule id="P10636-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11501.1">
<molecule id="P10636-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11502.1">
<molecule id="P10636-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45715.1">
<molecule id="P10636-9"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45716.1">
<molecule id="P10636-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56033.1">
<molecule id="P10636-5"/>
</dbReference>
<dbReference type="PIR" id="I52232">
<property type="entry name" value="I52232"/>
</dbReference>
<dbReference type="PIR" id="JS0370">
<property type="entry name" value="QRHUT1"/>
</dbReference>
<dbReference type="PIR" id="PN0001">
<property type="entry name" value="QRHUT2"/>
</dbReference>
<dbReference type="PIR" id="S26663">
<property type="entry name" value="S26663"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001116538.2">
<molecule id="P10636-9"/>
<property type="nucleotide sequence ID" value="NM_001123066.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001116539.1">
<molecule id="P10636-7"/>
<property type="nucleotide sequence ID" value="NM_001123067.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001190181.1">
<molecule id="P10636-5"/>
<property type="nucleotide sequence ID" value="NM_001203252.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005901.2">
<molecule id="P10636-8"/>
<property type="nucleotide sequence ID" value="NM_005910.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_058518.1">
<molecule id="P10636-6"/>
<property type="nucleotide sequence ID" value="NM_016834.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_058519.3">
<molecule id="P10636-1"/>
<property type="nucleotide sequence ID" value="NM_016835.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_058525.1">
<molecule id="P10636-2"/>
<property type="nucleotide sequence ID" value="NM_016841.4"/>
</dbReference>
<dbReference type="PDB" id="1I8H">
<property type="method" value="NMR"/>
<property type="chains" value="A=542-554"/>
</dbReference>
<dbReference type="PDB" id="2MZ7">
<property type="method" value="NMR"/>
<property type="chains" value="A=584-629"/>
</dbReference>
<dbReference type="PDB" id="2ON9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.51"/>
<property type="chains" value="A/B=623-628"/>
</dbReference>
<dbReference type="PDB" id="3OVL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A=623-628"/>
</dbReference>
<dbReference type="PDB" id="4E0M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B/C/D=622-634"/>
</dbReference>
<dbReference type="PDB" id="4E0N">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B/C/D=622-634"/>
</dbReference>
<dbReference type="PDB" id="4E0O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82"/>
<property type="chains" value="A/B/C/D=622-634"/>
</dbReference>
<dbReference type="PDB" id="4FL5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="P/Q=527-536"/>
</dbReference>
<dbReference type="PDB" id="4GLR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=541-557"/>
</dbReference>
<dbReference type="PDB" id="4NP8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.51"/>
<property type="chains" value="A=623-628"/>
</dbReference>
<dbReference type="PDB" id="4TQE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=532-547"/>
</dbReference>
<dbReference type="PDB" id="4Y32">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="C/D=528-534"/>
</dbReference>
<dbReference type="PDB" id="4Y3B">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="C/D=528-534"/>
</dbReference>
<dbReference type="PDB" id="4Y5I">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="F/G=528-534"/>
</dbReference>
<dbReference type="PDB" id="5DMG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="P/X/Z=733-747"/>
</dbReference>
<dbReference type="PDB" id="5E2V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.64"/>
<property type="chains" value="P=511-528"/>
</dbReference>
<dbReference type="PDB" id="5E2W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="P=511-528"/>
</dbReference>
<dbReference type="PDB" id="5HF3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="B=528-534"/>
</dbReference>
<dbReference type="PDB" id="5K7N">
<property type="method" value="EM"/>
<property type="resolution" value="1.10"/>
<property type="chains" value="Z=623-628"/>
</dbReference>
<dbReference type="PDB" id="5MO3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A=615-628"/>
</dbReference>
<dbReference type="PDB" id="5MP1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/E/I=615-628"/>
</dbReference>
<dbReference type="PDB" id="5MP3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="C/D=609-638"/>
</dbReference>
<dbReference type="PDB" id="5MP5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="I/J/K=615-628"/>
</dbReference>
<dbReference type="PDB" id="5N5A">
<property type="method" value="NMR"/>
<property type="chains" value="A=571-607"/>
</dbReference>
<dbReference type="PDB" id="5N5B">
<property type="method" value="NMR"/>
<property type="chains" value="A=609-636"/>
</dbReference>
<dbReference type="PDB" id="5NVB">
<property type="method" value="NMR"/>
<property type="chains" value="A=571-585"/>
</dbReference>
<dbReference type="PDB" id="5O3L">
<property type="method" value="EM"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=623-695"/>
</dbReference>
<dbReference type="PDB" id="5O3O">
<property type="method" value="EM"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=623-695"/>
</dbReference>
<dbReference type="PDB" id="5O3T">
<property type="method" value="EM"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=623-695"/>
</dbReference>
<dbReference type="PDB" id="5V5B">
<property type="method" value="EM"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=591-600"/>
</dbReference>
<dbReference type="PDB" id="5V5C">
<property type="method" value="EM"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="A=592-597"/>
</dbReference>
<dbReference type="PDB" id="5ZIA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C/F/J/N/Q/R=552-560"/>
</dbReference>
<dbReference type="PDB" id="5ZV3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A=52-71"/>
</dbReference>
<dbReference type="PDB" id="6BB4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="P/Q/R=703-725"/>
</dbReference>
<dbReference type="PDB" id="6CVJ">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="D=514-717"/>
</dbReference>
<dbReference type="PDB" id="6CVN">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="D=514-717"/>
</dbReference>
<dbReference type="PDB" id="6DC8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="P=696-725"/>
</dbReference>
<dbReference type="PDB" id="6DC9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="P/Q=696-725"/>
</dbReference>
<dbReference type="PDB" id="6DCA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="P/Q/R/S=696-725"/>
</dbReference>
<dbReference type="PDB" id="6FBW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="B/D=528-533"/>
</dbReference>
<dbReference type="PDB" id="6FI5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="B=529-533"/>
</dbReference>
<dbReference type="PDB" id="6GK7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=625-635"/>
</dbReference>
<dbReference type="PDB" id="6GK8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="I=52-71"/>
</dbReference>
<dbReference type="PDB" id="6GX5">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C=602-695"/>
</dbReference>
<dbReference type="PDB" id="6H06">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.63"/>
<property type="chains" value="G/I/J/K=721-746"/>
</dbReference>
<dbReference type="PDB" id="6HRE">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D/E/F=1-758"/>
</dbReference>
<dbReference type="PDB" id="6HRF">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C/D/E/F=1-758"/>
</dbReference>
<dbReference type="PDB" id="6N4P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/C=5-10"/>
</dbReference>
<dbReference type="PDB" id="6NK4">
<property type="method" value="EM"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="A=591-599"/>
</dbReference>
<dbReference type="PDB" id="6NWP">
<property type="method" value="EM"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D/E/F=1-758"/>
</dbReference>
<dbReference type="PDB" id="6NWQ">
<property type="method" value="EM"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B/C/D/E/F=1-758"/>
</dbReference>
<dbReference type="PDB" id="6ODG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.00"/>
<property type="chains" value="A/B=622-627"/>
</dbReference>
<dbReference type="PDB" id="6QJH">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C=589-647"/>
</dbReference>
<dbReference type="PDB" id="6QJM">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C=591-638"/>
</dbReference>
<dbReference type="PDB" id="6QJP">
<property type="method" value="EM"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B/C=591-638"/>
</dbReference>
<dbReference type="PDB" id="6QJQ">
<property type="method" value="EM"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A/B/C/D/E/F=620-647"/>
</dbReference>
<dbReference type="PDB" id="6TJO">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C=1-758"/>
</dbReference>
<dbReference type="PDB" id="6TJX">
<property type="method" value="EM"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C/D/E/F=1-758"/>
</dbReference>
<dbReference type="PDB" id="6VH7">
<property type="method" value="EM"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="A/B/C/E/F/G=591-697"/>
</dbReference>
<dbReference type="PDB" id="6VHA">
<property type="method" value="EM"/>
<property type="resolution" value="4.30"/>
<property type="chains" value="E/F/G=591-697"/>
</dbReference>
<dbReference type="PDB" id="6VHL">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="E/F=621-697"/>
</dbReference>
<dbReference type="PDB" id="6VI3">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="E/F=621-697"/>
</dbReference>
<dbReference type="PDBsum" id="1I8H"/>
<dbReference type="PDBsum" id="2MZ7"/>
<dbReference type="PDBsum" id="2ON9"/>
<dbReference type="PDBsum" id="3OVL"/>
<dbReference type="PDBsum" id="4E0M"/>
<dbReference type="PDBsum" id="4E0N"/>
<dbReference type="PDBsum" id="4E0O"/>
<dbReference type="PDBsum" id="4FL5"/>
<dbReference type="PDBsum" id="4GLR"/>
<dbReference type="PDBsum" id="4NP8"/>
<dbReference type="PDBsum" id="4TQE"/>
<dbReference type="PDBsum" id="4Y32"/>
<dbReference type="PDBsum" id="4Y3B"/>
<dbReference type="PDBsum" id="4Y5I"/>
<dbReference type="PDBsum" id="5DMG"/>
<dbReference type="PDBsum" id="5E2V"/>
<dbReference type="PDBsum" id="5E2W"/>
<dbReference type="PDBsum" id="5HF3"/>
<dbReference type="PDBsum" id="5K7N"/>
<dbReference type="PDBsum" id="5MO3"/>
<dbReference type="PDBsum" id="5MP1"/>
<dbReference type="PDBsum" id="5MP3"/>
<dbReference type="PDBsum" id="5MP5"/>
<dbReference type="PDBsum" id="5N5A"/>
<dbReference type="PDBsum" id="5N5B"/>
<dbReference type="PDBsum" id="5NVB"/>
<dbReference type="PDBsum" id="5O3L"/>
<dbReference type="PDBsum" id="5O3O"/>
<dbReference type="PDBsum" id="5O3T"/>
<dbReference type="PDBsum" id="5V5B"/>
<dbReference type="PDBsum" id="5V5C"/>
<dbReference type="PDBsum" id="5ZIA"/>
<dbReference type="PDBsum" id="5ZV3"/>
<dbReference type="PDBsum" id="6BB4"/>
<dbReference type="PDBsum" id="6CVJ"/>
<dbReference type="PDBsum" id="6CVN"/>
<dbReference type="PDBsum" id="6DC8"/>
<dbReference type="PDBsum" id="6DC9"/>
<dbReference type="PDBsum" id="6DCA"/>
<dbReference type="PDBsum" id="6FBW"/>
<dbReference type="PDBsum" id="6FI5"/>
<dbReference type="PDBsum" id="6GK7"/>
<dbReference type="PDBsum" id="6GK8"/>
<dbReference type="PDBsum" id="6GX5"/>
<dbReference type="PDBsum" id="6H06"/>
<dbReference type="PDBsum" id="6HRE"/>
<dbReference type="PDBsum" id="6HRF"/>
<dbReference type="PDBsum" id="6N4P"/>
<dbReference type="PDBsum" id="6NK4"/>
<dbReference type="PDBsum" id="6NWP"/>
<dbReference type="PDBsum" id="6NWQ"/>
<dbReference type="PDBsum" id="6ODG"/>
<dbReference type="PDBsum" id="6QJH"/>
<dbReference type="PDBsum" id="6QJM"/>
<dbReference type="PDBsum" id="6QJP"/>
<dbReference type="PDBsum" id="6QJQ"/>
<dbReference type="PDBsum" id="6TJO"/>
<dbReference type="PDBsum" id="6TJX"/>
<dbReference type="PDBsum" id="6VH7"/>
<dbReference type="PDBsum" id="6VHA"/>
<dbReference type="PDBsum" id="6VHL"/>
<dbReference type="PDBsum" id="6VI3"/>
<dbReference type="BMRB" id="P10636"/>
<dbReference type="SMR" id="P10636"/>
<dbReference type="BioGRID" id="110308">
<property type="interactions" value="239"/>
</dbReference>
<dbReference type="CORUM" id="P10636"/>
<dbReference type="DIP" id="DIP-29753N"/>
<dbReference type="ELM" id="P10636"/>
<dbReference type="IntAct" id="P10636">
<property type="interactions" value="579"/>
</dbReference>
<dbReference type="MINT" id="P10636"/>
<dbReference type="STRING" id="9606.ENSP00000340820"/>
<dbReference type="BindingDB" id="P10636"/>
<dbReference type="ChEMBL" id="CHEMBL1293224"/>
<dbReference type="DrugBank" id="DB00637">
<property type="generic name" value="Astemizole"/>
</dbReference>
<dbReference type="DrugBank" id="DB01248">
<property type="generic name" value="Docetaxel"/>
</dbReference>
<dbReference type="DrugBank" id="DB00448">
<property type="generic name" value="Lansoprazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB01229">
<property type="generic name" value="Paclitaxel"/>
</dbReference>
<dbReference type="DrugCentral" id="P10636"/>
<dbReference type="GlyConnect" id="2885">
<property type="glycosylation" value="1 O-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="P10636">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P10636"/>
<dbReference type="MetOSite" id="P10636"/>
<dbReference type="PhosphoSitePlus" id="P10636"/>
<dbReference type="BioMuta" id="MAPT"/>
<dbReference type="DMDM" id="334302961"/>
<dbReference type="EPD" id="P10636"/>
<dbReference type="jPOST" id="P10636"/>
<dbReference type="MassIVE" id="P10636"/>
<dbReference type="MaxQB" id="P10636"/>
<dbReference type="PaxDb" id="P10636"/>
<dbReference type="PeptideAtlas" id="P10636"/>
<dbReference type="PRIDE" id="P10636"/>
<dbReference type="ProteomicsDB" id="12705">
<molecule id="P10636-9"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52624">
<molecule id="P10636-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52625">
<molecule id="P10636-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52626">
<molecule id="P10636-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52627">
<molecule id="P10636-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52628">
<molecule id="P10636-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52629">
<molecule id="P10636-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52630">
<molecule id="P10636-7"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52631">
<molecule id="P10636-8"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52632">
<molecule id="P10636-9"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P10636-3">
<molecule id="P10636-3"/>
</dbReference>
<dbReference type="ABCD" id="P10636">
<property type="antibodies" value="76 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3124">
<property type="antibodies" value="5290 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4137"/>
<dbReference type="Ensembl" id="ENST00000262410">
<molecule id="P10636-1"/>
<property type="protein sequence ID" value="ENSP00000262410"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000334239">
<molecule id="P10636-2"/>
<property type="protein sequence ID" value="ENSP00000334886"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000340799">
<molecule id="P10636-7"/>
<property type="protein sequence ID" value="ENSP00000340438"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000344290">
<molecule id="P10636-9"/>
<property type="protein sequence ID" value="ENSP00000340820"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000351559">
<molecule id="P10636-8"/>
<property type="protein sequence ID" value="ENSP00000303214"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000415613">
<molecule id="P10636-9"/>
<property type="protein sequence ID" value="ENSP00000410838"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420682">
<molecule id="P10636-7"/>
<property type="protein sequence ID" value="ENSP00000413056"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000431008">
<molecule id="P10636-5"/>
<property type="protein sequence ID" value="ENSP00000389250"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000446361">
<molecule id="P10636-6"/>
<property type="protein sequence ID" value="ENSP00000408975"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000535772">
<molecule id="P10636-5"/>
<property type="protein sequence ID" value="ENSP00000443028"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000571987">
<molecule id="P10636-1"/>
<property type="protein sequence ID" value="ENSP00000458742"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000574436">
<molecule id="P10636-8"/>
<property type="protein sequence ID" value="ENSP00000460965"/>
<property type="gene ID" value="ENSG00000186868"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000612872">
<molecule id="P10636-7"/>
<property type="protein sequence ID" value="ENSP00000478602"/>
<property type="gene ID" value="ENSG00000277956"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000613360">
<molecule id="P10636-7"/>
<property type="protein sequence ID" value="ENSP00000483784"/>
<property type="gene ID" value="ENSG00000276155"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000620070">
<molecule id="P10636-8"/>
<property type="protein sequence ID" value="ENSP00000484491"/>
<property type="gene ID" value="ENSG00000277956"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000620818">
<molecule id="P10636-5"/>
<property type="protein sequence ID" value="ENSP00000484321"/>
<property type="gene ID" value="ENSG00000277956"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000620981">
<molecule id="P10636-5"/>
<property type="protein sequence ID" value="ENSP00000481769"/>
<property type="gene ID" value="ENSG00000276155"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000621329">
<molecule id="P10636-8"/>
<property type="protein sequence ID" value="ENSP00000477703"/>
<property type="gene ID" value="ENSG00000276155"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000622106">
<molecule id="P10636-6"/>
<property type="protein sequence ID" value="ENSP00000482244"/>
<property type="gene ID" value="ENSG00000277956"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000622728">
<molecule id="P10636-6"/>
<property type="protein sequence ID" value="ENSP00000479142"/>
<property type="gene ID" value="ENSG00000276155"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000626571">
<molecule id="P10636-6"/>
<property type="protein sequence ID" value="ENSP00000486039"/>
<property type="gene ID" value="ENSG00000276155"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000628393">
<molecule id="P10636-2"/>
<property type="protein sequence ID" value="ENSP00000487570"/>
<property type="gene ID" value="ENSG00000276155"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000631447">
<molecule id="P10636-5"/>
<property type="protein sequence ID" value="ENSP00000488373"/>
<property type="gene ID" value="ENSG00000277956"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000632500">
<molecule id="P10636-7"/>
<property type="protein sequence ID" value="ENSP00000487837"/>
<property type="gene ID" value="ENSG00000277956"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000633047">
<molecule id="P10636-2"/>
<property type="protein sequence ID" value="ENSP00000488245"/>
<property type="gene ID" value="ENSG00000277956"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000634049">
<molecule id="P10636-8"/>
<property type="protein sequence ID" value="ENSP00000487819"/>
<property type="gene ID" value="ENSG00000277956"/>
</dbReference>
<dbReference type="GeneID" id="4137"/>
<dbReference type="KEGG" id="hsa:4137"/>
<dbReference type="UCSC" id="uc002ijr.5">
<molecule id="P10636-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4137"/>
<dbReference type="DisGeNET" id="4137"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000186868.15"/>
<dbReference type="GeneCards" id="MAPT"/>
<dbReference type="GeneReviews" id="MAPT"/>
<dbReference type="HGNC" id="HGNC:6893">
<property type="gene designation" value="MAPT"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000186868">
<property type="expression patterns" value="Group enriched (brain, skeletal muscle)"/>
</dbReference>
<dbReference type="MalaCards" id="MAPT"/>
<dbReference type="MIM" id="157140">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="172700">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="260540">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600274">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601104">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P10636"/>
<dbReference type="NIAGADS" id="ENSG00000186868"/>
<dbReference type="OpenTargets" id="ENSG00000186868"/>
<dbReference type="Orphanet" id="275864">
<property type="disease" value="Behavioral variant of frontotemporal dementia"/>
</dbReference>
<dbReference type="Orphanet" id="240071">
<property type="disease" value="Classic progressive supranuclear palsy syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="100070">
<property type="disease" value="Progressive non-fluent aphasia"/>
</dbReference>
<dbReference type="Orphanet" id="240103">
<property type="disease" value="Progressive supranuclear palsy-corticobasal syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="240085">
<property type="disease" value="Progressive supranuclear palsy-parkinsonism syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="240112">
<property type="disease" value="Progressive supranuclear palsy-progressive non-fluent aphasia syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="240094">
<property type="disease" value="Progressive supranuclear palsy-pure akinesia with gait freezing syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="100069">
<property type="disease" value="Semantic dementia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA238"/>
<dbReference type="eggNOG" id="KOG2418">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155494"/>
<dbReference type="HOGENOM" id="CLU_021741_2_0_1"/>
<dbReference type="InParanoid" id="P10636"/>
<dbReference type="KO" id="K04380"/>
<dbReference type="OMA" id="EPRQEFN"/>
<dbReference type="OrthoDB" id="716848at2759"/>
<dbReference type="TreeFam" id="TF316358"/>
<dbReference type="PathwayCommons" id="P10636"/>
<dbReference type="Reactome" id="R-HSA-264870">
<property type="pathway name" value="Caspase-mediated cleavage of cytoskeletal proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9619483">
<molecule id="P10636-8"/>
<property type="pathway name" value="Activation of AMPK downstream of NMDARs"/>
</dbReference>
<dbReference type="SABIO-RK" id="P10636"/>
<dbReference type="SIGNOR" id="P10636"/>
<dbReference type="BioGRID-ORCS" id="4137">
<property type="hits" value="3 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MAPT">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P10636"/>
<dbReference type="GeneWiki" id="Tau_protein"/>
<dbReference type="GenomeRNAi" id="4137"/>
<dbReference type="Pharos" id="P10636">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P10636"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="P10636">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000186868">
<property type="expression patterns" value="Expressed in parietal lobe and 233 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P10636">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P10636">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030673">
<property type="term" value="C:axolemma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904115">
<property type="term" value="C:axon cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0044297">
<property type="term" value="C:cell body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036464">
<property type="term" value="C:cytoplasmic ribonucleoprotein granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097386">
<property type="term" value="C:glial cell projection"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030426">
<property type="term" value="C:growth cone"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044304">
<property type="term" value="C:main axon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005874">
<property type="term" value="C:microtubule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0015630">
<property type="term" value="C:microtubule cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097418">
<property type="term" value="C:neurofibrillary tangle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034399">
<property type="term" value="C:nuclear periphery"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036477">
<property type="term" value="C:somatodendritic compartment"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045298">
<property type="term" value="C:tubulin complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034185">
<property type="term" value="F:apolipoprotein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003680">
<property type="term" value="F:AT DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034452">
<property type="term" value="F:dynactin binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099077">
<property type="term" value="F:histone-dependent DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051879">
<property type="term" value="F:Hsp90 protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071813">
<property type="term" value="F:lipoprotein particle binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099609">
<property type="term" value="F:microtubule lateral binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0035091">
<property type="term" value="F:phosphatidylinositol binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902936">
<property type="term" value="F:phosphatidylinositol bisphosphate binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051721">
<property type="term" value="F:protein phosphatase 2A binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030674">
<property type="term" value="F:protein-macromolecule adaptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003697">
<property type="term" value="F:single-stranded DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990000">
<property type="term" value="P:amyloid fibril formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0048143">
<property type="term" value="P:astrocyte activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061564">
<property type="term" value="P:axon development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0098930">
<property type="term" value="P:axonal transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019896">
<property type="term" value="P:axonal transport of mitochondrion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990416">
<property type="term" value="P:cellular response to brain-derived neurotrophic factor stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034605">
<property type="term" value="P:cellular response to heat"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990090">
<property type="term" value="P:cellular response to nerve growth factor stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021954">
<property type="term" value="P:central nervous system neuron development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031122">
<property type="term" value="P:cytoplasmic microtubule organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048699">
<property type="term" value="P:generation of neurons"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006475">
<property type="term" value="P:internal protein amino acid acetylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048312">
<property type="term" value="P:intracellular distribution of mitochondria"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007613">
<property type="term" value="P:memory"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001774">
<property type="term" value="P:microglial cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000226">
<property type="term" value="P:microtubule cytoskeleton organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046785">
<property type="term" value="P:microtubule polymerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903748">
<property type="term" value="P:negative regulation of establishment of protein localization to mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033673">
<property type="term" value="P:negative regulation of kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090258">
<property type="term" value="P:negative regulation of mitochondrial fission"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010917">
<property type="term" value="P:negative regulation of mitochondrial membrane potential"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904428">
<property type="term" value="P:negative regulation of tubulin deacetylation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902988">
<property type="term" value="P:neurofibrillary tangle assembly"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031175">
<property type="term" value="P:neuron projection development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0072386">
<property type="term" value="P:plus-end-directed organelle transport along microtubule"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045773">
<property type="term" value="P:positive regulation of axon extension"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903829">
<property type="term" value="P:positive regulation of cellular protein localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1905689">
<property type="term" value="P:positive regulation of diacylglycerol kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031116">
<property type="term" value="P:positive regulation of microtubule polymerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901216">
<property type="term" value="P:positive regulation of neuron death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902474">
<property type="term" value="P:positive regulation of protein localization to synapse"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032930">
<property type="term" value="P:positive regulation of superoxide anion generation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051258">
<property type="term" value="P:protein polymerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050848">
<property type="term" value="P:regulation of calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900034">
<property type="term" value="P:regulation of cellular response to heat"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033044">
<property type="term" value="P:regulation of chromosome organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900452">
<property type="term" value="P:regulation of long-term synaptic depression"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070507">
<property type="term" value="P:regulation of microtubule cytoskeleton organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0031113">
<property type="term" value="P:regulation of microtubule polymerization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031110">
<property type="term" value="P:regulation of microtubule polymerization or depolymerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0090140">
<property type="term" value="P:regulation of mitochondrial fission"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001020">
<property type="term" value="P:regulation of response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048167">
<property type="term" value="P:regulation of synaptic plasticity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010288">
<property type="term" value="P:response to lead ion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016072">
<property type="term" value="P:rRNA metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034063">
<property type="term" value="P:stress granule assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097435">
<property type="term" value="P:supramolecular fiber organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0007416">
<property type="term" value="P:synapse assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050808">
<property type="term" value="P:synapse organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="DisProt" id="DP01100">
<molecule id="P10636-8"/>
</dbReference>
<dbReference type="InterPro" id="IPR027324">
<property type="entry name" value="MAP2/MAP4/Tau"/>
</dbReference>
<dbReference type="InterPro" id="IPR001084">
<property type="entry name" value="MAP_tubulin-bd_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR002955">
<property type="entry name" value="Tau"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11501">
<property type="entry name" value="PTHR11501"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00418">
<property type="entry name" value="Tubulin-binding"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PRINTS" id="PR01261">
<property type="entry name" value="TAUPROTEIN"/>
</dbReference>
<dbReference type="PROSITE" id="PS00229">
<property type="entry name" value="TAU_MAP_1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS51491">
<property type="entry name" value="TAU_MAP_2"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0026">Alzheimer disease</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0971">Glycation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0493">Microtubule</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0908">Parkinsonism</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="53">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Microtubule-associated protein tau" id="PRO_0000072739">
<location>
<begin position="2"/>
<end position="758"/>
</location>
</feature>
<feature type="repeat" description="Tau/MAP 1" evidence="18 93">
<location>
<begin position="561"/>
<end position="591"/>
</location>
</feature>
<feature type="repeat" description="Tau/MAP 2" evidence="18 93">
<location>
<begin position="592"/>
<end position="622"/>
</location>
</feature>
<feature type="repeat" description="Tau/MAP 3" evidence="18 93">
<location>
<begin position="623"/>
<end position="653"/>
</location>
</feature>
<feature type="repeat" description="Tau/MAP 4" evidence="18 93">
<location>
<begin position="654"/>
<end position="685"/>
</location>
</feature>
<feature type="region of interest" description="Microtubule-binding domain" evidence="75">
<location>
<begin position="561"/>
<end position="685"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="24"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="44"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="67"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="381"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="391"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="392"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="394"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="465"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="497"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="507"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="541"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="557"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="571"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="574"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="584"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="591"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="607"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="611"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="615"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="628"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="634"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="638"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="648"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="657"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="660"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="687"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="692"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="700"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="702"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="712"/>
</location>
</feature>
<feature type="site" description="Not glycated" evidence="77">
<location>
<position position="755"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="53">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FYN" evidence="52">
<location>
<position position="18"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="16">
<location>
<position position="29"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="46"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="61"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="69"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17">
<location>
<position position="71"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="111"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by SGK1" evidence="62">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; in PHF-tau" evidence="64">
<location>
<position position="396"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PDPK1" evidence="78">
<location>
<position position="470"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="16">
<location>
<position position="472"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="16">
<location>
<position position="480"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="480"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine; in tau and PHF-tau; partial" evidence="53">
<location>
<position position="484"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="486"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="492"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PDPK1" evidence="55">
<location>
<position position="498"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="502"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="508"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="512"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by TTBK1" evidence="61">
<location>
<position position="514"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PDPK1 and TTBK1" evidence="61">
<location>
<position position="515"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PDPK1 and TTBK1" evidence="55 61 65 78">
<location>
<position position="516"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1, PDPK1 and TTBK1" evidence="11 13 14 49 55 61 65 68 78">
<location>
<position position="519"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CK1 and PDPK1" evidence="49 55 65">
<location>
<position position="522"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by BRSK1, BRSK2, DYRK2 and PDPK1" evidence="55 63 65 69 78">
<location>
<position position="529"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="55 60 65 78">
<location>
<position position="531"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PDPK1" evidence="60 65">
<location>
<position position="534"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="16">
<location>
<position position="542"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by GSK3-beta and PDPK1" evidence="13 48 55 60">
<location>
<position position="548"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PDPK1" evidence="13 55 60 78">
<location>
<position position="552"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PHK" evidence="60 76">
<location>
<position position="554"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="576"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="16">
<location>
<position position="576"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MARK1, MARK2, MARK3, MARK4, BRSK1, BRSK2 and PHK" evidence="55 60 65 69 70 75 76 78">
<location>
<position position="579"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine; in tau and PHF-tau; partial" evidence="53">
<location>
<position position="596"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="598"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PHK" evidence="76">
<location>
<position position="602"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="16">
<location>
<position position="607"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="75">
<location>
<position position="610"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="615"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PHK" evidence="75 76">
<location>
<position position="622"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="16">
<location>
<position position="628"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="628"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="634"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="638"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="75">
<location>
<position position="641"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="648"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="660"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="664"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="16">
<location>
<position position="666"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PHK" evidence="76">
<location>
<position position="669"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="75">
<location>
<position position="673"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="686"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="702"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="16">
<location>
<position position="711"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1 and PDPK1" evidence="12 13 49 55 60 65 68 78">
<location>
<position position="713"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; alternate" evidence="12">
<location>
<position position="717"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="720"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1 and PDPK1" evidence="12 13 49 55 65 68 78">
<location>
<position position="721"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 55">
<location>
<position position="726"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CaMK2 and TTBK1" evidence="61">
<location>
<position position="733"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PDPK1 and TTBK1" evidence="60 61 65 78">
<location>
<position position="739"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by TTBK1" evidence="61">
<location>
<position position="744"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="87"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="383"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="467"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="480"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="491"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine" evidence="68">
<location>
<position position="525"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="542"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="551"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine" evidence="68">
<location>
<position position="555"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="576"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="597"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="598"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="664"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="670"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine; in PHF-tau; in vitro" evidence="77">
<location>
<position position="686"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" evidence="68">
<location>
<position position="717"/>
</location>
</feature>
<feature type="disulfide bond" evidence="15">
<location>
<begin position="608"/>
<end position="639"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="16">
<location>
<position position="44"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in PHF-tau" evidence="60">
<location>
<position position="571"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="576"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="16">
<location>
<position position="584"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="598"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="615"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in PHF-tau" evidence="60">
<location>
<position position="628"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="634"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="638"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="648"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="660"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="664"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in PHF-tau" evidence="60">
<location>
<position position="670"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="686"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="16">
<location>
<position position="692"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="702"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Tau-A." id="VSP_003175" evidence="87">
<original>MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLK</original>
<variation>MLRALQQRKR</variation>
<location>
<begin position="1"/>
<end position="44"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Tau-A, isoform Tau-D and isoform Fetal-tau." id="VSP_003176" evidence="84 86 87 88 91">
<location>
<begin position="45"/>
<end position="73"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Tau-A, isoform Tau-B, isoform Tau-D, isoform Tau-E and isoform Fetal-tau." id="VSP_003177" evidence="84 85 86 87 88 90 91">
<location>
<begin position="74"/>
<end position="102"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Tau-A." id="VSP_003178" evidence="87">
<location>
<begin position="103"/>
<end position="104"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Tau-A, isoform Tau-B, isoform Tau-C, isoform Tau-D, isoform Tau-E, isoform Tau-F and isoform Fetal-tau." id="VSP_003179" evidence="84 85 86 87 88 90 91">
<location>
<begin position="125"/>
<end position="375"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Tau-A, isoform Tau-B, isoform Tau-C, isoform Tau-D, isoform Tau-E, isoform Tau-F and isoform Fetal-tau." id="VSP_003180" evidence="84 85 86 87 88 90 91">
<location>
<begin position="395"/>
<end position="460"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Tau-G." id="VSP_026780" evidence="92">
<original>S</original>
<variation>SATKQVQRRPPPAGPRSER</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Tau-A, isoform Tau-B, isoform Tau-C and isoform Fetal-tau." id="VSP_003181" evidence="84 85 87 88 91">
<location>
<begin position="592"/>
<end position="622"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; reduces the ability of tau to promote microtubule assembly and promotes fibril formation in vitro; dbSNP:rs63750959." id="VAR_019660" evidence="41">
<original>R</original>
<variation>H</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence variant" description="In PSNP1; delays assembly initiation and lowers the mass of microtubules formed; but the assembly rate is increased compared to normal tau; dbSNP:rs63750959." id="VAR_019661" evidence="42">
<original>R</original>
<variation>L</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs144611688." id="VAR_064622" evidence="67">
<original>T</original>
<variation>M</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs748728879." id="VAR_064623" evidence="67">
<original>T</original>
<variation>A</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="Risk factor for PSNP1; dbSNP:rs62063786." id="VAR_010340" evidence="24 79">
<original>D</original>
<variation>N</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="Risk factor for PSNP1; dbSNP:rs62063787." id="VAR_010341" evidence="24 79">
<original>V</original>
<variation>A</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17651549." id="VAR_056121">
<original>R</original>
<variation>W</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2258689." id="VAR_010342" evidence="45 54 79">
<original>Y</original>
<variation>H</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10445337." id="VAR_010343" evidence="79">
<original>S</original>
<variation>P</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In PIDB; reduces the ability to promote microtubule assembly by 70%; dbSNP:rs63750129." id="VAR_010344" evidence="30 32">
<original>K</original>
<variation>T</variation>
<location>
<position position="574"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; less able to promote microtubule assembly than wild-type tau; dbSNP:rs63750349." id="VAR_019662" evidence="44">
<original>L</original>
<variation>V</variation>
<location>
<position position="583"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; dbSNP:rs63750376." id="VAR_010345" evidence="80 83">
<original>G</original>
<variation>V</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; with parkinsonism; dbSNP:rs63750756." id="VAR_010346" evidence="22 23 28 43 82">
<original>N</original>
<variation>K</variation>
<location>
<position position="596"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD." id="VAR_010347" evidence="83">
<location>
<position position="597"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; reduced the ability of tau to promote microtubule assembly without having a significant effect on tau filament formation; effects at both the RNA and the protein level; dbSNP:rs63750416." id="VAR_019663" evidence="36 40">
<original>N</original>
<variation>H</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In PSNP1/atypical PSNP1; heterozygosity may be a risk factor for both a PSNP1-like syndrome and Parkinson disease; reduced the ability of tau to promote microtubule assembly without having a significant effect on tau filament formation; effects at both the RNA and the protein level." id="VAR_019664" evidence="33 40 50 51">
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs116733906." id="VAR_064624" evidence="67">
<original>V</original>
<variation>I</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; most common mutation; reduction in the ability to promote microtubule assembly; accelerates aggregation of tau into filaments; dbSNP:rs63751273." id="VAR_010348" evidence="20 80 81 82 83">
<original>P</original>
<variation>L</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD and CBD; reduction in the ability to promote microtubule assembly; dbSNP:rs63751438." id="VAR_010349" evidence="21 25 29 59">
<original>P</original>
<variation>S</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In PSNP1; dbSNP:rs63751391." id="VAR_037439" evidence="58">
<original>G</original>
<variation>V</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; minimal parkinsonism; very early age of onset; dbSNP:rs63751165." id="VAR_010350" evidence="19">
<original>S</original>
<variation>N</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; dbSNP:rs63750092." id="VAR_037440" evidence="56">
<original>K</original>
<variation>M</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In PIDB; markedly reduced ability of tau to promote microtubule assembly; dbSNP:rs63750635." id="VAR_019665" evidence="39">
<original>S</original>
<variation>F</variation>
<location>
<position position="637"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; ultrastructural and biochemical characteristics indistinguishable from Alzheimer disease; accelerates aggregation of tau into filaments; dbSNP:rs63750570." id="VAR_010351" evidence="20 79">
<original>V</original>
<variation>M</variation>
<location>
<position position="654"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD; dbSNP:rs63750711." id="VAR_019666" evidence="31">
<original>E</original>
<variation>V</variation>
<location>
<position position="659"/>
</location>
</feature>
<feature type="sequence variant" description="In fatal respiratory hypoventilation; unusual apparent autosomal recessive inheritance; reduced binding to microtubules as well as increased fibrillization and aggregation; dbSNP:rs63750425." id="VAR_019667" evidence="47">
<original>S</original>
<variation>L</variation>
<location>
<position position="669"/>
</location>
</feature>
<feature type="sequence variant" description="In PIDB; 90% reduction in the rate of microtubule assembly; dbSNP:rs63751264." id="VAR_019668" evidence="37">
<original>K</original>
<variation>I</variation>
<location>
<position position="686"/>
</location>
</feature>
<feature type="sequence variant" description="In PIDB; in vitro the mutation reduces the ability of tau to promote microtubule assembly by 25 to 30%; dbSNP:rs63750512." id="VAR_010352" evidence="26 32">
<original>G</original>
<variation>R</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="sequence variant" description="In FTD/Alzheimer disease; accelerates aggregation of tau into filaments; reduces tau phosphorylation in cells compared to both the wild-type and other mutant forms; dbSNP:rs63750424." id="VAR_010353" evidence="20 34 38 46 72 80 83">
<original>R</original>
<variation>W</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="516"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="519"/>
</location>
</feature>
<feature type="mutagenesis site" description="No decrease in microtubule-binding and nucleation activity after in vitro phosphorylation of mutant protein.">
<original>S</original>
<variation>A</variation>
<location>
<position position="531"/>
</location>
</feature>
<feature type="mutagenesis site" description="50% Decrease in microtubule-binding after in vitro phosphorylation of mutant protein.">
<original>T</original>
<variation>A</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>T</original>
<variation>E</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="mutagenesis site" description="70% decrease in microtubule-binding after in vitro phosphorylation of mutant protein.">
<original>S</original>
<variation>A</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="8% decrease in microtubule-binding after in vitro phosphorylation of mutant protein.">
<original>S</original>
<variation>A</variation>
<location>
<position position="579"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="713"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="730"/>
</location>
</feature>
<feature type="mutagenesis site" description="No association with plasma membrane.">
<original>S</original>
<variation>E</variation>
<location>
<position position="739"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAU45390." ref="6" evidence="92">
<original>L</original>
<variation>P</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAC04277." ref="5" evidence="92">
<original>H</original>
<variation>L</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; AAS17881." ref="12" evidence="92">
<original>K</original>
<variation>M</variation>
<location>
<position position="557"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; AAS17881." ref="12" evidence="92">
<original>K</original>
<variation>S</variation>
<location>
<position position="591"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 17; AA sequence." ref="17" evidence="92">
<original>V</original>
<variation>Q</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 17; AA sequence." ref="17" evidence="92">
<original>S</original>
<variation>K</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="60"/>
<end position="62"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="579"/>
<end position="582"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="587"/>
<end position="590"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="592"/>
<end position="596"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="598"/>
<end position="601"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="603"/>
<end position="607"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="611"/>
<end position="617"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="618"/>
<end position="620"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="622"/>
<end position="624"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="625"/>
<end position="627"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="634"/>
<end position="640"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="642"/>
<end position="647"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="654"/>
<end position="663"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="667"/>
<end position="675"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="677"/>
<end position="679"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="682"/>
<end position="684"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="686"/>
<end position="695"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="739"/>
<end position="741"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4E0N"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5MP5"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5N5A"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5N5B"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5ZV3"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6CVJ"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6GX5"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6H06"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NWP"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6TJX"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250"/>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P10637"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P19332"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00824"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10208578"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10214944"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10374757"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10412802"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10489057"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10534245"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10553987"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10604746"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10747907"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10802785"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11071507"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11089577"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11117541"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11117542"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11220749"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278002"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11313338"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11585254"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11601501"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11889249"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11891833"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11906000"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11921059"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12325083"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12473774"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12509859"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1420178"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14517953"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14595660"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14690523"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14761950"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14991828"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14991829"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14999081"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1512244"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15365985"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15546861"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15883319"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15953362"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16157753"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16240366"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16443603"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16923168"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16982696"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18599021"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1899488"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19451179"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19542233"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20020531"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21327254"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21985311"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23666762"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26014385"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26086902"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="32272059"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="32296178"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7706316"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8999860"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9326300"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9614189"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9629852"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9641683"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9736786"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9789048"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9973279"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2484340"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2498079"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2516729"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3131773"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9789048"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="91" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="92" type="ECO:0000305"/>
<evidence key="93" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7706316"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:6893"/>
</source>
</evidence>
<sequence length="758" mass="78928" checksum="D46C66CDBCD196E8" modified="2011-05-31" version="5">MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQEPESGKVVQEGFLREPGPPGLSHQLMSGMPGAPLLPEGPREATRQPSGTGPEDTEGGRHAPELLKHQLLGDLHQEGPPLKGAGGKERPGSKEEVDEDRDVDESSPQDSPPSKASPAQDGRPPQTAAREATSIPGFPAEGAIPLPVDFLSKVSTEIPASEPDGPSVGRAKGQDAPLEFTFHVEITPNVQKEQAHSEEHLGRAAFPGAPGEGPEARGPSLGEDTKEADLPEPSEKQPAAAPRGKPVSRVPQLKARMVSKSKDGTGSDDKKAKTSTRSSAKTLKNRPCLSPKHPTPGSSDPLIQPSSPAVCPEPPSSPKYVSSVTSRTGSSGAKEMKLKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

